Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Mar. 31, 2021 | May 07, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2021 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q3 | |
Trading Symbol | PCSB | |
Entity Registrant Name | PCSB Financial Corporation | |
Entity Central Index Key | 0001691337 | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | true | |
Entity Common Stock, Shares Outstanding | 15,966,216 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Shell Company | false | |
Title of 12(b) Security | Common Stock, $0.01 par value per share | |
Security Exchange Name | NASDAQ | |
Entity File Number | 001-38065 | |
Entity Incorporation, State or Country Code | MD | |
Entity Tax Identification Number | 81-4710738 | |
Entity Address, Address Line One | 2651 Strang Blvd | |
Entity Address, Address Line Two | Suite 100 | |
Entity Address, City or Town | Yorktown Heights | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10598 | |
City Area Code | 914 | |
Local Phone Number | 248-7272 | |
Document Quarterly Report | true | |
Document Transition Report | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
ASSETS | ||
Cash and due from banks | $ 167,983 | $ 135,045 |
Federal funds sold | 1,331 | 1,257 |
Total cash and cash equivalents | 169,314 | 136,302 |
Investment securities: | ||
Held to maturity debt securities, at amortized cost (fair value of $313,974 and $281,497, respectively) | 309,692 | 275,772 |
Available for sale debt securities, at fair value | 37,610 | 37,426 |
Total investment securities | 347,302 | 313,198 |
Loans receivable, net of allowance for loan losses of $7,865 and $8,639, respectively | 1,261,155 | 1,260,947 |
Accrued interest receivable | 6,731 | 6,880 |
FHLB stock | 5,854 | 6,308 |
Premises and equipment, net | 19,364 | 20,853 |
Deferred tax asset, net | 3,163 | 3,129 |
Bank-owned life insurance | 25,400 | 25,019 |
Goodwill | 6,106 | 6,106 |
Other intangible assets | 168 | 229 |
Other assets | 10,117 | 12,958 |
Total assets | 1,854,674 | 1,791,929 |
LIABILITIES AND SHAREHOLDERS' EQUITY | ||
Interest bearing deposits | 1,250,945 | 1,181,357 |
Non-interest bearing deposits | 203,345 | 191,898 |
Total deposits | 1,454,290 | 1,373,255 |
Mortgage escrow funds | 9,252 | 10,123 |
Advances from FHLB | 95,991 | 106,089 |
Other liabilities | 23,844 | 28,749 |
Total liabilities | 1,583,377 | 1,518,216 |
Commitments and contingencies | ||
Shareholders' equity: | ||
Preferred stock ($0.01 par value, 10,000,000 shares authorized, no shares issued or outstanding as of March 31, 2021 and June 30, 2020) | ||
Common stock ($0.01 par value, 200,000,000 shares authorized, 18,703,577 and 18,712,295 shares issued as of March 31, 2021 and June 30, 2020, respectively, and 15,966,216 and 16,898,137 shares outstanding as of March 31, 2021 and June 30, 2020, respectively) | 187 | 187 |
Additional paid in capital | 188,926 | 186,200 |
Retained earnings | 148,466 | 141,288 |
Unearned compensation - ESOP | (10,418) | (11,145) |
Accumulated other comprehensive loss, net of income taxes | (6,180) | (6,403) |
Treasury stock, at cost (2,737,361 and 1,814,158 shares as of March 31, 2021 and June 30, 2020, respectively) | (49,684) | (36,414) |
Total shareholders' equity | 271,297 | 273,713 |
Total liabilities and shareholders' equity | $ 1,854,674 | $ 1,791,929 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Statement Of Financial Position [Abstract] | ||
Held to maturity investment securities, fair value | $ 313,974 | $ 281,497 |
Allowance for loan losses | $ 7,865 | $ 8,639 |
Preferred Stock, par value | $ 0.01 | $ 0.01 |
Preferred Stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred Stock, shares issued | 0 | 0 |
Preferred Stock, shares outstanding | 0 | 0 |
Common Stock, par value | $ 0.01 | $ 0.01 |
Common Stock, shares authorized | 200,000,000 | 200,000,000 |
Common Stock, shares, issued | 18,703,577 | 18,712,295 |
Common Stock, shares outstanding | 15,966,216 | 16,898,137 |
Treasury Stock, Shares | 2,737,361 | 1,814,158 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | ||
Interest and dividend income | |||||
Loans receivable | $ 12,116,000 | $ 13,114,000 | $ 36,845,000 | $ 39,299,000 | |
Investment securities | 1,700,000 | 2,003,000 | 5,489,000 | 6,974,000 | |
Federal funds and other | 109,000 | 217,000 | 344,000 | 816,000 | |
Total interest and dividend income | 13,925,000 | 15,334,000 | 42,678,000 | 47,089,000 | |
Interest expense | |||||
Deposits and escrow interest | 1,782,000 | 3,268,000 | 6,372,000 | 9,927,000 | |
FHLB advances | 506,000 | 541,000 | 1,545,000 | 1,942,000 | |
Total interest expense | 2,288,000 | 3,809,000 | 7,917,000 | 11,869,000 | |
Net interest income | 11,637,000 | 11,525,000 | 34,761,000 | 35,220,000 | |
Provision (benefit) for loan losses | (894,000) | 2,008,000 | (678,000) | 2,755,000 | |
Net interest income after provision for loan losses | 12,531,000 | 9,517,000 | 35,439,000 | 32,465,000 | |
Noninterest income | |||||
Fees and service charges | 353,000 | 366,000 | 1,038,000 | 1,170,000 | |
Bank-owned life insurance | [1] | 120,000 | 128,000 | 381,000 | 399,000 |
Swap income | [1] | 367,000 | 170,000 | ||
Gains on sales of securities | [1] | 113,000 | 38,000 | 113,000 | 38,000 |
Other | 6,000 | 48,000 | 30,000 | 115,000 | |
Total noninterest income | 592,000 | 580,000 | 1,929,000 | 1,892,000 | |
Noninterest expense | |||||
Salaries and employee benefits | 5,595,000 | 5,782,000 | 16,722,000 | 17,435,000 | |
Occupancy and equipment | 1,359,000 | 1,311,000 | 4,051,000 | 3,959,000 | |
Communication and data processing | 517,000 | 521,000 | 1,539,000 | 1,559,000 | |
Professional fees | 382,000 | 393,000 | 1,285,000 | 1,176,000 | |
Postage, printing, stationery and supplies | 146,000 | 140,000 | 452,000 | 439,000 | |
FDIC assessment | 115,000 | 350,000 | |||
Advertising | 100,000 | 100,000 | 300,000 | 300,000 | |
Amortization of intangible assets | 21,000 | 24,000 | 61,000 | 73,000 | |
Other operating expenses | 337,000 | 249,000 | 1,127,000 | 1,160,000 | |
Total noninterest expense | 8,572,000 | 8,520,000 | 25,887,000 | 26,101,000 | |
Net income before income tax expense | 4,551,000 | 1,577,000 | 11,481,000 | 8,256,000 | |
Income tax expense | 959,000 | 360,000 | 2,467,000 | 1,857,000 | |
Net income | $ 3,592,000 | $ 1,217,000 | $ 9,014,000 | $ 6,399,000 | |
Earnings per common share: | |||||
Basic | $ 0.25 | $ 0.08 | $ 0.60 | $ 0.41 | |
Diluted | $ 0.25 | $ 0.08 | $ 0.60 | $ 0.40 | |
Weighted average common shares outstanding: | |||||
Basic | 14,631,122 | 15,437,173 | 14,944,097 | 15,752,709 | |
Diluted | 14,632,342 | 15,447,217 | 14,944,664 | 15,814,322 | |
[1] | Not within the scope of ASC 606 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Net income | $ 3,592 | $ 1,217 | $ 9,014 | $ 6,399 |
Unrealized (losses) gains on available for sale debt securities: | ||||
Net change in unrealized gains/losses before reclassification adjustment | (565) | 186 | (584) | 406 |
Reclassification adjustment for gains realized in net income | (52) | (20) | (52) | (20) |
Net change in unrealized gains/losses | (617) | 166 | (636) | 386 |
Tax effect | 129 | (35) | 133 | (80) |
Net of tax | (488) | 131 | (503) | 306 |
Defined benefit pension plan and supplemental retirement plans: | ||||
Total other comprehensive (loss) income | (235) | 244 | 223 | 860 |
Comprehensive income | 3,357 | 1,461 | 9,237 | 7,259 |
Pension Benefits [Member] | ||||
Defined benefit pension plan and supplemental retirement plans: | ||||
Reclassification adjustment for amortization of prior service cost and net gain included in net periodic pension cost | 305 | 132 | 877 | 668 |
Tax effect | (64) | (27) | (184) | (139) |
Net of tax | 241 | 105 | 693 | 529 |
SERP Benefits [Member] | ||||
Defined benefit pension plan and supplemental retirement plans: | ||||
Reclassification adjustment for amortization of prior service cost and net gain included in net periodic pension cost | 14 | 11 | 42 | 34 |
Tax effect | (2) | (3) | (9) | (9) |
Net of tax | $ 12 | $ 8 | $ 33 | $ 25 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands | Total | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Unallocated Common Stock of ESOP [Member] | Treasury Stock, at Cost [Member] | Accumulated Other Comprehensive Loss [Member] |
Beginning Balance at Jun. 30, 2019 | $ 281,307 | $ 187 | $ 182,129 | $ 134,500 | $ (12,114) | $ (18,305) | $ (5,090) |
Begining Balance (in shares) at Jun. 30, 2019 | 17,804,039 | ||||||
Net income | 2,829 | 2,829 | |||||
Other comprehensive income (loss) | 256 | 256 | |||||
Common stock dividends declared | (659) | (659) | |||||
Repurchase of common stock | (3,524) | (3,524) | |||||
Repurchase of common stock (in shares) | (179,800) | ||||||
Stock-based compensation | 830 | 830 | |||||
ESOP shares committed to be released | 483 | 239 | 244 | ||||
Ending Balance at Sep. 30, 2019 | 281,522 | $ 187 | 183,198 | 136,670 | (11,870) | (21,829) | (4,834) |
Ending Balance (in shares) at Sep. 30, 2019 | 17,624,239 | ||||||
Beginning Balance at Jun. 30, 2019 | 281,307 | $ 187 | 182,129 | 134,500 | (12,114) | (18,305) | (5,090) |
Begining Balance (in shares) at Jun. 30, 2019 | 17,804,039 | ||||||
Net income | 6,399 | ||||||
Other comprehensive income (loss) | 860 | 860 | |||||
Ending Balance at Mar. 31, 2020 | 272,417 | $ 187 | 185,301 | 138,957 | (11,384) | (36,414) | (4,230) |
Ending Balance (in shares) at Mar. 31, 2020 | 16,898,137 | ||||||
Beginning Balance at Sep. 30, 2019 | 281,522 | $ 187 | 183,198 | 136,670 | (11,870) | (21,829) | (4,834) |
Begining Balance (in shares) at Sep. 30, 2019 | 17,624,239 | ||||||
Net income | 2,353 | 2,353 | |||||
Other comprehensive income (loss) | 360 | 360 | |||||
Common stock dividends declared | (650) | (650) | |||||
Repurchase of common stock | (4,748) | (4,748) | |||||
Repurchase of common stock (in shares) | (236,050) | ||||||
Shares withheld related to income tax withholding | (320) | (320) | |||||
Shares withheld related to income tax withholding (in shares) | (15,881) | ||||||
Stock-based compensation | 829 | 829 | |||||
ESOP shares committed to be released | 493 | 249 | 244 | ||||
Ending Balance at Dec. 31, 2019 | 279,839 | $ 187 | 184,276 | 138,373 | (11,626) | (26,897) | (4,474) |
Ending Balance (in shares) at Dec. 31, 2019 | 17,372,308 | ||||||
Net income | 1,217 | 1,217 | |||||
Other comprehensive income (loss) | 244 | 244 | |||||
Common stock dividends declared | (633) | (633) | |||||
Repurchase of common stock | (9,517) | (9,517) | |||||
Repurchase of common stock (in shares) | (474,171) | ||||||
Stock-based compensation | 829 | 829 | |||||
ESOP shares committed to be released | 438 | 196 | 242 | ||||
Ending Balance at Mar. 31, 2020 | 272,417 | $ 187 | 185,301 | 138,957 | (11,384) | (36,414) | (4,230) |
Ending Balance (in shares) at Mar. 31, 2020 | 16,898,137 | ||||||
Beginning Balance at Jun. 30, 2020 | 273,713 | $ 187 | 186,200 | 141,288 | (11,145) | (36,414) | (6,403) |
Begining Balance (in shares) at Jun. 30, 2020 | 16,898,137 | ||||||
Net income | 2,728 | 2,728 | |||||
Other comprehensive income (loss) | 187 | 187 | |||||
Common stock dividends declared | (630) | (630) | |||||
Repurchase of common stock | (3,449) | (3,449) | |||||
Repurchase of common stock (in shares) | (266,900) | ||||||
Restricted stock awards granted | (60) | 60 | |||||
Restricted stock awards granted (in shares) | 3,000 | ||||||
Stock-based compensation | 829 | 829 | |||||
ESOP shares committed to be released | 301 | 57 | 244 | ||||
Ending Balance at Sep. 30, 2020 | 273,679 | $ 187 | 187,026 | 143,386 | (10,901) | (39,803) | (6,216) |
Ending Balance (in shares) at Sep. 30, 2020 | 16,634,237 | ||||||
Beginning Balance at Jun. 30, 2020 | 273,713 | $ 187 | 186,200 | 141,288 | (11,145) | (36,414) | (6,403) |
Begining Balance (in shares) at Jun. 30, 2020 | 16,898,137 | ||||||
Net income | 9,014 | ||||||
Other comprehensive income (loss) | 223 | 223 | |||||
Ending Balance at Mar. 31, 2021 | 271,297 | $ 187 | 188,926 | 148,466 | (10,418) | (49,684) | (6,180) |
Ending Balance (in shares) at Mar. 31, 2021 | 15,966,216 | ||||||
Beginning Balance at Sep. 30, 2020 | 273,679 | $ 187 | 187,026 | 143,386 | (10,901) | (39,803) | (6,216) |
Begining Balance (in shares) at Sep. 30, 2020 | 16,634,237 | ||||||
Net income | 2,694 | 2,694 | |||||
Other comprehensive income (loss) | 271 | 271 | |||||
Common stock dividends declared | (608) | (608) | |||||
Repurchase of common stock | (7,591) | (7,591) | |||||
Repurchase of common stock (in shares) | (517,270) | ||||||
Shares withheld related to income tax withholding | (303) | (303) | |||||
Shares withheld related to income tax withholding (in shares) | (19,100) | ||||||
Stock-based compensation | 822 | 822 | |||||
ESOP shares committed to be released | 360 | 116 | 244 | ||||
Ending Balance at Dec. 31, 2020 | 269,324 | $ 187 | 187,964 | 145,472 | (10,657) | (47,697) | (5,945) |
Ending Balance (in shares) at Dec. 31, 2020 | 16,097,867 | ||||||
Net income | 3,592 | 3,592 | |||||
Other comprehensive income (loss) | (235) | (235) | |||||
Common stock dividends declared | (598) | (598) | |||||
Repurchase of common stock | (1,987) | (1,987) | |||||
Repurchase of common stock (in shares) | (122,933) | ||||||
Forfeiture of restricted stock (in shares) | (8,718) | ||||||
Stock-based compensation | 809 | 809 | |||||
ESOP shares committed to be released | 392 | 153 | 239 | ||||
Ending Balance at Mar. 31, 2021 | $ 271,297 | $ 187 | $ 188,926 | $ 148,466 | $ (10,418) | $ (49,684) | $ (6,180) |
Ending Balance (in shares) at Mar. 31, 2021 | 15,966,216 |
Consolidated Statements of Ch_2
Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) - $ / shares | 3 Months Ended | |||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | |
Statement Of Stockholders Equity [Abstract] | ||||||
Common stock dividends declared (per share) | $ 0.04 | $ 0.04 | $ 0.04 | $ 0.04 | $ 0.04 | $ 0.04 |
ESOP shares committed to be released (in shares) | 23,888 | 24,419 | 24,419 | 24,154 | 24,419 | 24,419 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | ||
OPERATING ACTIVITIES | |||
Net income | $ 9,014,000 | $ 6,399,000 | |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Provision (benefit) for loan losses | (678,000) | 2,755,000 | |
Depreciation and amortization | 2,226,000 | 2,223,000 | |
Amortization of net premiums on securities and net deferred loan origination costs | 681,000 | 1,242,000 | |
Net decrease (increase) in accrued interest receivable | 149,000 | (587,000) | |
Net gains on sales of foreclosed real estate | (87,000) | ||
Net gains on sales of securities | [1] | (113,000) | (38,000) |
Stock-based compensation | 2,460,000 | 2,487,000 | |
ESOP compensation | 1,053,000 | 1,415,000 | |
Earnings from cash surrender value of BOLI | (381,000) | (399,000) | |
Net accretion of purchase accounting adjustments | (193,000) | (437,000) | |
Other adjustments, principally net changes in other assets and liabilities | (1,682,000) | (474,000) | |
Net cash provided by operating activities | 12,536,000 | 14,499,000 | |
Purchases of investment securities: | |||
Held to maturity | (102,412,000) | (13,189,000) | |
Available for sale | (20,377,000) | ||
Sales of investment securities available for sale | 3,339,000 | 4,245,000 | |
Maturities, calls and amortization of investment securities: | |||
Held to maturity | 67,814,000 | 99,572,000 | |
Available for sale | 16,120,000 | 22,148,000 | |
Loan principal repayments (disbursements), net | 871,000 | (86,045,000) | |
Purchase of loans | (44,579,000) | ||
Net redemption of FHLB stock | 454,000 | 229,000 | |
Purchase of bank premises and equipment, net of sales | (233,000) | (563,000) | |
Purchase of BOLI | (200,000) | ||
Proceeds from sales of foreclosed real estate | 1,578,000 | ||
Net cash used in investing activities | (34,424,000) | (16,804,000) | |
FINANCING ACTIVITIES | |||
Net increase in deposits | 81,035,000 | 53,765,000 | |
Net decrease in short-term FHLB advances | (10,000,000) | (50,000,000) | |
Proceeds from long-term FHLB advances | 50,000,000 | ||
Repayment of long-term FHLB advances | (98,000) | (5,095,000) | |
Net decrease in mortgage escrow funds | (871,000) | (1,431,000) | |
Common stock dividends paid | (1,836,000) | (1,942,000) | |
Repurchase of shares from employees for income tax withholding purpose | (303,000) | (320,000) | |
Repurchase of common stock | (13,027,000) | (17,789,000) | |
Net cash provided by financing activities | 54,900,000 | 27,188,000 | |
Net increase in cash and cash equivalents | 33,012,000 | 24,883,000 | |
Cash and cash equivalents at beginning of period | 136,302,000 | 60,029,000 | |
Cash and cash equivalents at end of period | 169,314,000 | 84,912,000 | |
Cash paid for: | |||
Interest | 7,935,000 | 11,822,000 | |
Income taxes | 2,764,000 | 2,069,000 | |
Loans transferred to foreclosed real estate | 333,000 | ||
Establishment of right to use lease asset | $ 443,000 | $ 12,687,000 | |
[1] | Not within the scope of ASC 606 |
Basis of Presentation
Basis of Presentation | 9 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Note 1. Basis of Presentation Nature of Operations PCSB Bank is a community-oriented financial institution that provides financial services to individuals and businesses within its market area of Putnam, Southern Dutchess, Rockland and Westchester Counties in New York. The Bank is a state-chartered commercial bank, and its deposits are insured up to applicable limits by the Deposit Insurance Fund of the Federal Deposit Insurance Corporation (“FDIC”). The Bank’s primary regulators are the FDIC and the NYSDFS. Basis of Presentation The unaudited consolidated financial statements contained herein reflect all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. Such adjustments are the only adjustments reflected in the consolidated financial statements contained herein. The results of operations for the current period presented are not necessarily indicative of the results of operations that may be expected for the entire current fiscal year. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The accompanying unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended June 30, 2020, included in the Company's Annual Report on Form 10-K. Certain prior period amounts have been reclassified to conform to the current presentation. Reclassifications had no effect on prior period net income or equity. Risks and Uncertainties: The COVID-19 pandemic has created extensive disruptions to the global and U.S. economies and to the lives of individuals throughout the world. The New York City Metropolitan area and environs have had one of the highest incidences of COVID-19 in the nation, and the neighboring Tri-State area of New Jersey and Connecticut also has been particularly affected by COVID-19. Governments, businesses, and the public are taking unprecedented actions to contain the spread of COVID-19 and to mitigate its effects, including quarantines, travel bans, shelter-in-place orders, closures of businesses and schools, fiscal and monetary stimulus, and legislation designed to deliver financial aid and other relief. While the scope, duration, and full effects of COVID-19 continue to evolve and are not fully known, the pandemic and the efforts to contain it have disrupted global economic activity, adversely affected the functioning of financial markets, impacted market interest rates, increased economic and market uncertainty, and disrupted trade and supply chains. The ultimate financial impact of the pandemic is unknown at this time. However, if these actions are sustained, it may continue to adversely impact several industries within our geographic footprint and impair the ability of the Company’s customers to fulfill their contractual obligations to the Company. This could cause the Company to experience a material adverse effect on our business operations, asset valuations, financial condition, and results of operations. Material adverse impacts may include all or a combination of valuation impairments of the Company’s intangible assets, investments, loans, or deferred tax assets. It is reasonably possible that the Company’s allowance for loan losses as of March 31, 2021 will change in the near term and could result in a material change to the Company’s provision for loan losses, earnings and capital. Use of Estimates |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 9 Months Ended |
Mar. 31, 2021 | |
Accounting Changes And Error Corrections [Abstract] | |
Recent Accounting Pronouncements | Note 2 . Recent Accounting Pronouncements The pronouncements discussed below are not intended to be an all-inclusive list, but rather only those pronouncements that the Company has determined could potentially have a material impact on our financial position, results of operations or disclosures. There were no accounting standards adopted in the current period. Future Application of Accounting Pronouncements Previously Issued In June 2016, the FASB issued ASU 2016-13 “Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 affects entities holding financial assets that are not accounted for at fair value through net income, including loans, debt securities, and other financial assets. The ASU requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected by recording an allowance for current expected credit losses. In October 2019, the FASB unanimously voted to delay the implementation of the standard for three years for certain companies, including small reporting companies (as defined by the SEC), non-SEC public companies and private companies. The Company currently qualifies as a small reporting company and is subject to the delayed implementation. Therefore, t he amendments in this update will be effective for the Company for the fiscal year beginning on July 1, 2023, including interim periods within that fiscal year. The Company is actively working through the provisions of the Update. Management has established a steering committee which is identifying the methodologies and the additional data requirements necessary to implement the Update and has engaged a third-party software service provider to assist in the Company's implementation. Management is currently evaluating the impact that ASU 2016-13 will have on the Company’s consolidated financial position, results of operations and disclosures. |
Investment Securities
Investment Securities | 9 Months Ended |
Mar. 31, 2021 | |
Investments Debt And Equity Securities [Abstract] | |
Investment Securities | Note 3. Investment Securities The amortized cost, gross unrealized/unrecognized gains and losses and fair value of available for sale and held to maturity debt securities at March 31, 2021 and June 30, 2020 were as follows: March 31, 2021 Amortized Gross Unrealized/Unrecognized Fair Cost Gains Losses Value (in thousands) Available for sale: U.S. Government and agency obligations $ 1,000 $ 4 $ - $ 1,004 Corporate 8,020 85 - 8,105 State and municipal 7,041 33 (210 ) 6,864 Mortgage-backed securities – residential 21,643 279 (285 ) 21,637 Total available for sale $ 37,704 $ 401 $ (495 ) $ 37,610 Held to maturity: U.S. Government and agency obligations $ 43,493 $ 261 $ (91 ) $ 43,663 Corporate 43,612 1,171 (127 ) 44,656 State and municipal 41,356 207 (843 ) 40,720 Mortgage-backed securities – residential 83,862 3,058 (113 ) 86,807 Mortgage-backed securities – collateralized mortgage obligations 45,260 935 (138 ) 46,057 Mortgage-backed securities – commercial 52,109 587 (625 ) 52,071 Total held to maturity $ 309,692 $ 6,219 $ (1,937 ) $ 313,974 June 30, 2020 Amortized Gross Unrealized/Unrecognized Fair Cost Gains Losses Value (in thousands) Available for sale: U.S. Government and agency obligations $ 11,002 $ 47 $ - $ 11,049 Corporate 5,038 82 - 5,120 Mortgage-backed securities – residential 20,844 428 (15 ) 21,257 Total available for sale $ 36,884 $ 557 $ (15 ) $ 37,426 Held to maturity: U.S. Government and agency obligations $ 42,001 $ 454 $ (5 ) $ 42,450 Corporate 43,634 142 (1,459 ) 42,317 State and municipal 9,156 190 (51 ) 9,295 Mortgage-backed securities – residential 117,160 4,291 (17 ) 121,434 Mortgage-backed securities – collateralized mortgage obligations 45,047 1,487 (31 ) 46,503 Mortgage-backed securities – commercial 18,774 724 - 19,498 Total held to maturity $ 275,772 $ 7,288 $ (1,563 ) $ 281,497 During the three and nine months ended March 31, 2021, the Company sold $5.0 million of securities which resulted in $113,000 of realized gains, which included the disposal of $1.6 million of securities classified as held to maturity, resulting in $61,000 of realized gains. These held to maturity securities were comprised of seasoned mortgage-backed securities where the Company collected a substantial portion (at least 85%) of the principal outstanding at acquisition due to prepayments or scheduled payments payable in equal installments, comparing both principal and interest over terms. During the three and nine months ended March 31, 2020, the Company sold $4.7 million of securities which resulted in $38,000 of realized gains, which included the disposal of $426,000 of securities classified as held to maturity, resulting in $17,000 of realized gains. The following table presents the fair value and carrying amount of debt securities at March 31, 2021, by contractual maturity (in thousands). Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date, primarily mortgage-backed securities, are shown separately. Held to maturity Available for sale Carrying Fair Amortized Fair Amount Value Cost Value 1 year or less $ 6,035 $ 6,084 $ 4,020 $ 4,076 1 to 5 years 48,159 48,381 2,000 2,017 5 to 10 years 33,702 34,645 3,000 3,017 over 10 years 36,638 35,856 7,041 6,863 Mortgage-backed securities and other 185,158 189,008 21,643 21,637 Total $ 309,692 $ 313,974 $ 37,704 $ 37,610 Securities pledged had carrying amounts of $183.2 million and $182.2 million at March 31, 2021 and June 30, 2020, respectively, and were pledged principally to secure FHLB advances and public deposits. The following table provides information regarding investment securities with unrealized/unrecognized losses, aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position at March 31, 2021 and June 30, 2020 March 31, 2021 Less than 12 months 12 months or greater Total Unrealized/ Unrealized/ Unrealized/ Fair Unrecognized Fair Unrecognized Fair Unrecognized Value Loss Value Loss Value Loss (in thousands) Available for sale: State and municipal $ 4,790 $ (210 ) $ - $ - $ 4,790 $ (210 ) Mortgage-backed securities – residential 9,852 (274 ) 1,365 (11 ) 11,217 (285 ) Total available for sale $ 14,642 $ (484 ) $ 1,365 $ (11 ) $ 16,007 $ (495 ) Held to maturity: U.S. Government and agency obligations $ 11,403 $ (91 ) $ - $ - $ 11,403 $ (91 ) Corporate 2,481 (18 ) 14,969 (109 ) 17,450 (127 ) State and municipal 28,818 (843 ) - - 28,818 (843 ) Mortgage-backed securities – residential 7,805 (113 ) - - 7,805 (113 ) Mortgage-backed securities – collateralized mortgage obligations 16,541 (138 ) - - 16,541 (138 ) Mortgage-backed securities – commercial 24,315 (625 ) - - 24,315 (625 ) Total held to maturity $ 91,363 $ (1,828 ) $ 14,969 $ (109 ) $ 106,332 $ (1,937 ) June 30, 2020 Less than 12 months 12 months or greater Total Unrealized/ Unrealized/ Unrealized/ Fair Unrecognized Fair Unrecognized Fair Unrecognized Value Loss Value Loss Value Loss (in thousands) Available for sale Mortgage-backed securities – residential $ 1,450 $ (15 ) $ - $ - $ 1,450 $ (15 ) Total available for sale $ 1,450 $ (15 ) $ - $ - $ 1,450 $ (15 ) Held to maturity U.S. Government and agency obligations $ 11,995 $ (5 ) $ - $ - $ 11,995 $ (5 ) Corporate 25,615 (1,004 ) 12,045 (455 ) 37,660 (1,459 ) State and municipal 5,136 (51 ) - - 5,136 (51 ) Mortgage-backed securities – residential 5,130 (17 ) - - 5,130 (17 ) Mortgage-backed securities – collateralized mortgage obligations 2,627 (31 ) - - 2,627 (31 ) Total held to maturity $ 50,503 $ (1,108 ) $ 12,045 $ (455 ) $ 62,548 $ (1,563 ) As of March 31, 2021, the Company’s securities portfolio consisted of $347.3 million in securities, of which 57 securities with a fair value of $122.3 million were in an unrealized loss position. The majority of unrealized losses are related to the Company’s state, municipal and corporate securities which are internally pass rated and are subject to quarterly credit monitoring. With the exception of these securities, all other investments are guaranteed by the U.S. government or its agencies. At March 31, 2021 and June 30, 2020, there were no holdings of securities of any one issuer, other than the U.S. government and its agencies, in an amount greater than 10% of shareholders’ equity. There were no securities as of March 31, 2021 or June 30, 2020 for which the Company believes it is not probable that it will collect all amounts due according to the contractual terms of the security. Management believes the unrealized losses are primarily a result of changes in interest rates and credit spreads. The Company has determined that it does not intend to sell, or it is not more likely than not that it will be required to sell, its securities that are in an unrealized loss position prior to the recovery of its amortized cost basis. Therefore, the Company did not consider any securities to be other-than-temporarily impaired as of March 31, 2021 or June 30, 2020. |
Loans Receivable
Loans Receivable | 9 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Loans Receivable | Note 4. Loans Receivable Loans receivable are summarized as follows (in thousands): March 31, June 30, 2021 2020 Mortgage loans: Residential $ 229,008 $ 255,382 Commercial 831,162 807,106 Construction 10,047 11,053 Net deferred loan origination costs 365 739 Total mortgage loans 1,070,582 1,074,280 Commercial and consumer loans: Commercial loans 171,314 164,257 Home equity lines of credit 27,211 29,838 Consumer and overdrafts 269 481 Net deferred loan origination costs (356 ) 730 Total commercial and consumer loans 198,438 195,306 Total loans receivable 1,269,020 1,269,586 Allowance for loan losses (7,865 ) (8,639 ) Loans receivable, net $ 1,261,155 $ 1,260,947 The following tables present the activity in the allowance for loan losses by portfolio segment for the three and nine months ended March 31, 2021 and 2020 (in thousands): Three Months Ended March 31, 2021 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 334 $ (4 ) $ - $ 2 $ 332 Commercial mortgages 6,872 (354 ) - - 6,518 Construction 205 (103 ) - - 102 Commercial loans 1,201 (437 ) (21 ) 105 848 Home equity lines of credit 61 (1 ) - 2 62 Consumer and overdrafts 4 5 (6 ) - 3 Total $ 8,677 $ (894 ) $ (27 ) $ 109 $ 7,865 Three Months Ended March 31, 2020 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 352 $ 102 $ - $ 3 $ 457 Commercial mortgages 4,568 1,099 - 125 5,792 Construction 273 173 - - 446 Commercial loans 953 600 - - 1,553 Home equity lines of credit 60 23 - 2 85 Consumer and overdrafts 10 11 (9 ) 1 13 Total $ 6,216 $ 2,008 $ (9 ) $ 131 $ 8,346 Nine Months Ended March 31, 2021 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 373 $ (49 ) $ - $ 8 $ 332 Commercial mortgages 6,913 (395 ) - - 6,518 Construction 165 (63 ) - - 102 Commercial loans 1,124 (187 ) (245 ) 156 848 Home equity lines of credit 60 (4 ) - 6 62 Consumer and installment loans 4 20 (23 ) 2 3 Total $ 8,639 $ (678 ) $ (268 ) $ 172 $ 7,865 Nine Months Ended March 31, 2020 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 446 $ 34 $ (31 ) $ 8 $ 457 Commercial mortgages 3,853 1,814 - 125 5,792 Construction 159 287 - - 446 Commercial loans 1,130 573 (150 ) - 1,553 Home equity lines of credit 65 10 - 10 85 Consumer and installment loans 11 37 (42 ) 7 13 Total $ 5,664 $ 2,755 $ (223 ) $ 150 $ 8,346 The following tables present the balance in the allowance for loan losses and the recorded investment in loans, excluding net deferred fees and accrued interest, by portfolio segment, and based on impairment method as of March 31, 2021 and June 30, 2020 (in thousands): March 31, 2021 Loans Allowance for Loan Losses Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Residential mortgages $ 2,238 $ 226,049 $ 721 $ 229,008 $ 114 $ 218 $ - $ 332 Commercial mortgages - 830,264 898 831,162 - 6,518 - 6,518 Construction - 10,047 - 10,047 - 102 - 102 Commercial loans 1,739 169,575 - 171,314 - 848 - 848 Home equity lines of credit 410 26,674 127 27,211 9 53 - 62 Consumer and overdrafts - 269 - 269 - 3 - 3 Total $ 4,387 $ 1,262,878 $ 1,746 $ 1,269,011 $ 123 $ 7,742 $ - $ 7,865 June 30, 2020 Loans Allowance for Loan Losses Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Residential mortgages $ 2,448 $ 252,195 $ 739 $ 255,382 $ 118 $ 255 $ - $ 373 Commercial mortgages - 806,224 882 807,106 - 6,913 - 6,913 Construction - 11,053 - 11,053 - 165 - 165 Commercial loans 1,921 162,336 - 164,257 1 1,123 - 1,124 Home equity lines of credit 350 29,349 139 29,838 4 56 - 60 Consumer and overdrafts - 481 - 481 - 4 - 4 Total $ 4,719 $ 1,261,638 $ 1,760 $ 1,268,117 $ 123 $ 8,516 $ - $ 8,639 The following tables present information related to loans individually evaluated for impairment (excluding loans acquired with deteriorated credit quality) by portfolio segment as of March 31, 2021 and June 30, 2020 (in thousands): March 31, 2021 June 30, 2020 Unpaid Principal Balance Recorded Investment Allowance for Loan Losses Unpaid Principal Balance Recorded Investment Allowance for Loan Losses With no related allowance recorded: Residential mortgages $ 1,926 $ 1,812 $ - $ 2,123 $ 2,013 $ - Commercial loans 1,909 1,739 - 2,067 1,897 - Home equity lines of credit 358 379 - 326 339 - With an allowance recorded: Residential mortgages 365 426 114 372 435 118 Commercial loans - - - 24 24 1 Home equity lines of credit 31 31 9 11 11 4 Total $ 4,589 $ 4,387 $ 123 $ 4,923 $ 4,719 $ 123 The tables below present the average recorded investment and interest income recognized on loans individually evaluated for impairment, by portfolio segment, for the three and nine months ended March 31, 2021 and 2020 (in thousands): Three months ended Three months ended March 31, 2021 March 31, 2020 Average Recorded Investment Interest Income Recognized Average Recorded Investment Interest Income Recognized With no related allowance recorded: Residential mortgages $ 1,822 $ 7 $ 2,060 $ 13 Commercial mortgages - - 485 9 Commercial loans 1,749 47 1,932 51 Home equity lines of credit 379 - 403 7 With an allowance recorded: Residential mortgages 427 4 435 4 Commercial loans - - 38 - Home equity lines of credit 30 - 11 (6 ) Total $ 4,407 $ 58 $ 5,364 $ 78 Nine Months Ended Nine Months Ended March 31, 2021 March 31, 2020 Average Recorded Investment Interest Income Recognized Average Recorded Investment Interest Income Recognized With no related allowance recorded: Residential mortgages $ 1,905 $ 27 $ 2,050 $ 40 Commercial mortgages - - 946 149 Commercial loans 1,786 144 2,015 154 Home equity lines of credit 384 1 574 20 With an allowance recorded: Residential mortgages 429 11 437 11 Commercial loans - - 42 1 Home equity lines of credit 24 - 11 - Total $ 4,528 $ 183 $ 6,075 $ 375 The following table presents the recorded investment in nonaccrual loans and in loans past due over 90 days and still on accrual status, by portfolio segment, as of March 31, 2021 and June 30, 2020 (in thousands): Loans Past Due Over 90 Days Nonaccrual and Still Accruing March 31, June 30, March 31, June 30, 2021 2020 2021 2020 Residential mortgages $ 1,267 $ 1,457 $ - $ - Commercial mortgages - - 408 - Home equity lines of credit 379 338 - - Total $ 1,646 $ 1,795 $ 408 $ - Nonperforming loans include both smaller-balance homogeneous loans that are collectively evaluated for impairment and individually classified impaired loans. The table above excludes acquired loans that are accounted for as purchased credit impaired loans totaling $372,000 and $392,000 as of March 31, 2021 and June 30, 2020, respectively. Such loans are excluded because the loans are in pools that are considered performing. The discounts arising from recording these loans at fair value upon acquisition were due in part to credit quality and the accretable yield is being recognized as interest income over the life of the loans based on expected cash flows. The following tables present the aging of the recorded investment in past due loans by portfolio segment as of March 31, 2021 and June 30, 2020 (in thousands): March 31, 2021 30-59 60-89 90 Days or Days Past Days Past More Past Total Past Due Due Due Due Current (1) Total Residential mortgages $ - $ - $ 939 $ 939 $ 228,069 $ 229,008 Commercial mortgages - - 408 408 830,754 831,162 Construction - - - - 10,047 10,047 Commercial loans 54 226 - 280 171,034 171,314 Home equity lines of credit - - 379 379 26,832 27,211 Consumer and overdrafts - - - - 269 269 Total $ 54 $ 226 $ 1,726 $ 2,006 $ 1,267,005 $ 1,269,011 June 30, 2020 30-59 60-89 90 Days or Days Past Days Past More Past Total Past Due Due Due Due Current (1) Total Residential mortgages $ 495 $ 10 $ 806 $ 1,311 $ 254,071 $ 255,382 Commercial mortgages - - - - 807,106 807,106 Construction - - - - 11,053 11,053 Commercial loans 76 - - 76 164,181 164,257 Home equity lines of credit 44 - 338 382 29,456 29,838 Consumer and overdrafts - - - - 481 481 Total $ 615 $ 10 $ 1,144 $ 1,769 $ 1,266,348 $ 1,268,117 (1) As of March 31, 2021 and June 30, 2020, loans on a COVID-19-related payment deferral of $34.4 million and $200.6 million, respectively, are considered current. Troubled Debt Restructurings The terms of certain loans have been modified as troubled debt restructurings (“TDR”). The modification of the terms of such loans included one or a combination of the following: a reduction of the stated interest rate of the loan; an extension of the maturity date at a stated rate of interest lower than the current market rate for new debt with similar risk; or a permanent reduction of the recorded investment in the loan. All TDRs are considered impaired loans. As of March 31, 2021 and June 30, 2020, the Company had 13 and 14 loans, classified as TDRs totaling $3.1 million and $3.3 million, including $2.7 million and $2.9 million, respectively, of loans still accruing interest. The Company has allocated $123,000 of specific reserves to customers whose loan terms have been modified in TDRs as of both March 31, 2021 and June 30, 2020. As of March 31, 2021, the Company has committed to lend an additional $5,000 to customers with outstanding loans that are classified as TDRs. The Company did not modify any loans during the three or nine months ended March 31, 2021 that were classified as TDRs. The Company modified one and two commercial loans in troubled debt restructurings during the three and nine months ended March 31, 2020, respectively. These loans had a carrying amount as of March 31, 2020 of $156,000. There were no defaults of troubled debt restructurings occurring in the three or nine months ended March 31, 2021 that were modified in the twelve months prior to default. The Company had one TDR, a residential mortgage loan with a carrying amount of $370,000 as of March 31, 2020, default in the nine months ended March 31, 2020 that was modified in the twelve months prior to default, with no such defaults occurring in the three months ended March 31, 2020. In order to determine whether a borrower is experiencing financial difficulty, an evaluation is performed of the probability that the borrower will be in payment default on any of its debt in the foreseeable future without the modification. This evaluation is performed under the Company’s internal underwriting policy. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. Section 4013 of the CARES Act, “Temporary Relief From Troubled Debt Restructurings,” provides banks the option to temporarily suspend certain requirements under U.S. GAAP related to TDRs for a limited period of time to account for the effects of COVID-19. On December 27, 2020, the Consolidated Appropriations Act 2021 was signed into law. Section 541 of this legislation, “Extension of Temporary Relief From Troubled Debt Restructurings and Insurer Clarification,” extends Section 4013 of the CARES Act to the earlier of January 1, 2022 or 60 days after the termination of the national emergency declared relating to COVID-19. Additionally, on April 7, 2020, the banking agencies, including the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation, issued a statement, “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working With Customers Affected by the Coronavirus (Revised)” (“Interagency Statement”), to encourage banks to work prudently with borrowers and to describe the agencies’ interpretation of how accounting rules under ASC 310-40, “Troubled Debt Restructurings by Creditors,” apply to certain COVID-19-related modifications. During the nine months ended March 31, 2021, the Company granted or extended loan payment deferrals for 31 residential mortgage loans and home equity lines of credit totaling $9.7 million, as well as 35 commercial mortgage, construction and commercial loans totaling $41.6 million. In accordance with either the CARES Act (as amended) or Interagency Statement, these modifications are not considered troubled debt restructurings. The Company had 35 and 293 loans totaling $34.4 million and $200.6 million on loan payment deferral as of March 31, 2021 and June 30, 2020, respectively. Credit Quality Indicators The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as: current financial information, historical payment experience, credit documentation, public information, and current economic trends, among other factors. The Company analyzes loans individually by classifying the loans as to credit risk. This analysis includes non-homogeneous loans, such as commercial and commercial real estate loans. This analysis is performed on a monthly basis. The Company utilizes the same grading process for acquired loans as it does for originated loans. The Company uses the following definitions for risk ratings: Special Mention – Loans classified as special mention have a potential weakness that deserves management's close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the institution's credit position at some future date. Substandard – Loans classified as substandard are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Doubtful – Loans classified as doubtful have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Loans not meeting the criteria above that are analyzed individually as part of the above-described process and loans in groups of homogenous loans are considered to be pass rated loans. These loans are monitored based on delinquency and performance. Based on the most recent analysis performed, the risk category of loans by portfolio segment is as follows (in thousands): March 31, 2021 Pass Special Mention Substandard Total Residential mortgages $ 224,725 $ 2,358 $ 1,925 $ 229,008 Commercial mortgages 814,173 1,627 15,362 831,162 Construction 10,047 - - 10,047 Commercial loans 167,309 94 3,911 171,314 Home equity lines of credit 25,870 902 439 27,211 Consumer and overdrafts 269 - - 269 Total $ 1,242,393 $ 4,981 $ 21,637 $ 1,269,011 June 30, 2020 Pass Special Mention Substandard Total Residential mortgages $ 252,604 $ 687 $ 2,091 $ 255,382 Commercial mortgages 803,048 3,176 882 807,106 Construction 11,053 - - 11,053 Commercial loans 160,137 201 3,919 164,257 Home equity lines of credit 28,894 498 446 29,838 Consumer and overdrafts 481 - - 481 Total $ 1,256,217 $ 4,562 $ 7,338 $ 1,268,117 As of March 31, 2021, of the $34.4 million in loans in a COVID-19 related payment deferral, $16.4 million were pass-rated, with $2.6 million and $15.3 million rated special mention and substandard, respectively. As of June 30, 2020, of the $200.6 million in loans on deferral, $195.4 million and $5.2 million were rated pass and substandard, respectively. Purchased Credit Impaired Loans The Company has acquired loans for which there was, at acquisition, evidence of deterioration of credit quality since origination and it was probable, at acquisition, that all contractually required payments would not be collected. The carrying amount of those loans as of March 31, 2021 and June 30, 2020 is as follows (in thousands): March 31, June 30, 2021 2020 Residential mortgages $ 721 $ 739 Commercial mortgages 898 882 Home equity lines of credit 127 139 Carrying amount, net of allowance of $0 $ 1,746 $ 1,760 There was no provision for loan losses on purchased credit impaired loans during the three or nine months ended March 31, 2021 and 2020. Accretable yield, or income expected to be collected, for acquired loans is as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2021 2020 2021 2020 Beginning balance $ 147 $ 174 $ 156 $ 192 New loans acquired - - - - Accretion income (9 ) (9 ) (18 ) (27 ) Reclassification from non-accretable difference - - - - Disposals - - - - Ending balance $ 138 $ 165 $ 138 $ 165 |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) | 9 Months Ended |
Mar. 31, 2021 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Income (Loss) | Note 5. Accumulated Other Comprehensive Income (Loss) The following is a summary of the accumulated other comprehensive income (loss) balances, net of tax (in thousands): Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at January 1, 2021 $ 413 $ (6,153 ) $ (205 ) $ (5,945 ) Other comprehensive loss before reclassifications (565 ) - - (565 ) Amounts reclassified from accumulated other comprehensive income (52 ) 305 14 267 Less tax effect 129 (64 ) (2 ) 63 Net other comprehensive (loss) income (488 ) 241 12 (235 ) Balance at March 31, 2021 $ (75 ) $ (5,912 ) $ (193 ) $ (6,180 ) Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at January 1, 2020 $ (34 ) $ (4,207 ) $ (233 ) $ (4,474 ) Other comprehensive income before reclassifications 186 - - 186 Amounts reclassified from accumulated other comprehensive income (20 ) 132 11 123 Less tax effect (35 ) (27 ) (3 ) (65 ) Net other comprehensive income 131 105 8 244 Balance at March 31, 2020 $ 97 $ (4,102 ) $ (225 ) $ (4,230 ) Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at July 1, 2020 $ 428 $ (6,605 ) $ (226 ) $ (6,403 ) Other comprehensive loss before reclassifications (584 ) - - (584 ) Amounts reclassified from accumulated other comprehensive income (52 ) 877 42 867 Tax effect 133 (184 ) (9 ) (60 ) Net other comprehensive (loss) income (503 ) 693 33 223 Balance at March 31, 2021 $ (75 ) $ (5,912 ) $ (193 ) $ (6,180 ) Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at July 1, 2019 $ (209 ) $ (4,631 ) $ (250 ) $ (5,090 ) Other comprehensive income before reclassifications 406 - - 406 Amounts reclassified from accumulated other comprehensive income (20 ) 668 34 682 Tax effect (80 ) (139 ) (9 ) (228 ) Net other comprehensive income 306 529 25 860 Balance at March 31, 2020 $ 97 $ (4,102 ) $ (225 ) $ (4,230 ) |
Post-Retirement Benefits
Post-Retirement Benefits | 9 Months Ended |
Mar. 31, 2021 | |
Compensation And Retirement Disclosure [Abstract] | |
Post-Retirement Benefits | Note 6 . Post-Retirement Benefits Employee Pension Plan The Company maintains a non-contributory defined benefit pension plan that covers employees meeting specific requirements as to age and length of service. The Company’s contributions to this qualified plan are determined on the basis of (i) the maximum amount that can be deducted for federal income tax purposes, and (ii) the amount determined by a consulting actuary as necessary to avoid an accumulated funding deficiency as defined by the Employee Retirement Income Security Act of 1974 (“ERISA”). Contributions are intended to provide for benefits attributed to service to date but also those expected to be earned in the future. Supplemental Executive Retirement Plans The Company also maintains unfunded and non-qualified supplemental executive retirement plans ("SERP") to provide pension benefits in addition to those provided under the qualified pension plan. Net periodic benefit cost and other amounts recognized in other comprehensive income for the three and nine months ended March 31, 2021 and 2020 (in thousands): Three Months Ended Three Months Ended March 31, 2021 March 31, 2020 Defined Benefit Plan Supplemental Retirement Plans Defined Benefit Plan Supplemental Retirement Plans Service cost $ - $ 130 $ - $ 90 Interest cost 136 18 180 28 Expected return on plan assets (455 ) - (479 ) - Amortization of prior net loss 241 14 132 11 Settlement charges 65 - - - Net periodic (benefit) cost $ (13 ) $ 162 $ (167 ) $ 129 Nine Months Ended Nine Months Ended March 31, 2021 March 31, 2020 Defined Benefit Plan Supplemental Retirement Plan Defined Benefit Plan Supplemental Retirement Plan Service cost $ - $ 311 $ - $ 248 Interest cost 409 65 540 89 Expected return on plan assets (1,366 ) - (1,436 ) - Amortization of prior net loss 720 42 396 34 Settlement charges 158 - 272 - Net periodic (benefit) cost $ (79 ) $ 418 $ (228 ) $ 371 The Company made no contributions to the defined benefit plan during the three or nine months ended March 31, 2021. Employee Stock Ownership Plan On January 1, 2017, the Company established an Employee Stock Ownership Plan (“ESOP”) to provide eligible employees the opportunity to own Company stock. The ESOP is a tax-qualified retirement plan for the benefit of Company employees. On April 20, 2017, the Company granted a loan to the ESOP for the purchase of 1,453,209 shares of the Company’s common stock at a price of $10.00 per share. The loan obtained by the ESOP from the Company to purchase the common stock is payable annually over 15 years at a rate per annum equal to the Prime Rate, reset annually on January 1st (3.25% Shares held by the ESOP include the following (dollars in thousands): March 31, 2021 June 30, 2020 Allocated to participants 402,362 327,206 Unearned 1,041,802 1,114,529 Total ESOP shares 1,444,164 1,441,735 Fair value of unearned shares $ 17,304 $ 14,132 Total compensation expense recognized in connection with the ESOP for the three and nine $438,000 and $1.4 million, respectively. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 9 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Note 7. Fair Value of Financial Instruments Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values: Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. A description of the valuation methodologies used for assets and liabilities measured at fair value, as well as general classification of such instruments pursuant to the valuation hierarchy, is set forth below. While management believes the Company’s valuation methodologies are appropriate and consistent with other financial institutions, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. Investment Securities Impaired Loans : The fair value of collateral-dependent impaired loans with specific allocations of the allowance for loan losses is generally based on recent real estate appraisals. Appraisals are generally obtained annually and may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are typically significant and result in a Level 3 classification of the inputs for determining fair value. Management performs a review of all appraisals, including any such adjustments. The fair value of uncollateralized or non-collateral-dependent loans are generally based on discounted cash flows which utilize management’s assumption of discount rates and expected future cash flows, resulting in a Level 3 classification. Foreclosed Real Estate Foreclosed properties are evaluated on a quarterly basis for additional impairment and adjusted accordingly. Appraisals for both collateral-dependent impaired loans and real estate owned are performed by certified general appraisers (for commercial properties) or certified residential appraisers (for residential properties) whose qualifications and licenses have been reviewed and verified by the Company. Once received, a member of the Credit Department, as well as a third-party specialist, where deemed appropriate, reviews the assumptions and approaches utilized in the appraisal as well as the overall resulting fair value in comparison with independent data sources such as recent market data or industry-wide statistics. Once appraisals are considered appropriate, management discounts the appraised value for estimated selling costs, such as legal, broker, and property maintenance and insurance costs. The most recent analysis performed indicated discount rates ranging between 10% and 20% should be applied to properties with appraisals performed. Derivatives Assets and liabilities measured at fair value are summarized below (in thousands): Fair Value Measurements Level 1 Level 2 Level 3 Total March 31, 2021 Measured on a recurring basis: Available for sale securities: U.S. Government and agency obligations $ - $ 1,004 $ - $ 1,004 Corporate - 8,105 - 8,105 State and municipal - 6,864 - 6,864 Mortgage-backed securities – residential - 21,637 - 21,637 Derivatives – interest rate contracts - 4,425 - 4,425 Total assets at fair value $ - $ 42,035 $ - $ 42,035 Derivatives – interest rate contracts $ - $ 4,425 $ - $ 4,425 Total liabilities at fair value $ - $ 4,425 $ - $ 4,425 Measured on a non-recurring basis: Impaired loans: Residential mortgages $ - $ - $ 312 $ 312 Home equity lines of credit - - 21 21 Total assets at fair value $ - $ - $ 333 $ 333 Fair Value Measurements Level 1 Level 2 Level 3 Total June 30, 2020 Measured on a recurring basis: Available for sale securities: U.S. Government and agency obligations $ - $ 11,049 $ - $ 11,049 Corporate - 5,120 - 5,120 Mortgage-backed securities – residential - 21,257 - 21,257 Derivatives – interest rate contracts - 8,305 - 8,305 Total assets at fair value $ - $ 45,731 $ - $ 45,731 Derivatives – interest rate contracts $ - $ 8,305 $ - $ 8,305 Total liabilities at fair value $ - $ 8,305 $ - $ 8,305 Measured on a non-recurring basis: Impaired loans: Residential mortgages $ - $ - $ 317 $ 317 Commercial loans - - 100 100 Home equity lines of credit - - 7 7 Total assets at fair value $ - $ - $ 424 $ 424 There were no transfers between levels within the fair value hierarchy during the three or nine months ended March 31, 2021 and 2020. Impaired loans in the preceding table had a carrying amount of $456,000 and a remaining valuation allowance of $123,000, at March 31, 2021, as compared to $547,000 and $123,000, respectively, as of June 30, 2020. Impaired loans measured at fair value incurred no net charge-offs and resulted in a benefit for loan losses of $1,000 during the nine months ended March 31, 2021. Impaired loans measured at fair value as of March 31, 2020 incurred no net charge-offs and resulted in an additional credit for loan losses of $6,000 during the nine months ended March 31, 2020. The following tables present quantitative information about Level 3 fair value measurements for selected financial instruments measured at fair value on a non-recurring basis at March 31, 2021 and June 30, 2020 (dollars in thousands): Valuation Unobservable Range or Fair Value Technique(s) Input(s) Rate Used March 31, 2021 Impaired loans - residential mortgages $ 312 Discounted cash flow Discount rate 5.4% to 6.3% Impaired loans - home equity lines of credit 21 Discounted cash flow Discount rate 5.4% to 6.3% June 30, 2020 Impaired loans - residential mortgages $ 316 Discounted cash flow Discount rate 5.4% to 6.3% Impaired loans - home equity lines of credit 7 Discounted cash flow Discount rate 6.3% Impaired loans - commercial loans 100 Discounted cash flow Discount rate 6.8% to 7.5% The following is a summary of the carrying amounts and estimated fair values of the Company’s financial assets and liabilities, none of which are held for trading purposes (in thousands): Carrying Fair Value Measurements Amount Level 1 Level 2 Level 3 Total March 31, 2021 Financial assets: Cash and cash equivalents $ 169,314 $ 169,314 $ - $ - $ 169,314 Investment securities held to maturity 309,692 - 286,539 27,435 313,974 Investment securities available for sale 37,610 - 37,610 - 37,610 Loans receivable, net 1,261,155 - - 1,240,645 1,240,645 Accrued interest receivable 6,731 - 1,300 5,431 6,731 FHLB stock 5,854 N/A N/A N/A N/A Derivative assets - interest rate contracts 4,425 - 4,425 - 4,425 Financial liabilities: Demand, NOW, money market deposits and savings accounts 1,046,464 1,046,464 - - 1,046,464 Time deposits 407,826 - 414,737 - 414,737 Mortgage escrow funds 9,252 9,252 - - 9,252 Accrued interest payable 228 1 227 - 228 FHLB advances 95,991 - 99,550 - 99,550 Derivative liabilities - interest rate contracts 4,425 - 4,425 - 4,425 Carrying Fair Value Measurements Amount Level 1 Level 2 Level 3 Total June 30, 2020 Financial assets: Cash and cash equivalents $ 136,302 $ 136,302 $ - $ - $ 136,302 Investment securities held to maturity 275,772 - 276,847 4,650 281,497 Investment securities available for sale 37,426 - 37,426 - 37,426 Loans receivable, net 1,260,947 - - 1,240,440 1,240,440 Accrued interest receivable 6,880 - 997 5,883 6,880 FHLB stock 6,308 N/A N/A N/A N/A Derivative assets - interest rate contracts 8,305 - 8,305 - 8,305 Financial liabilities: Demand, NOW, money market deposits and savings accounts 926,989 926,989 - - 926,989 Time deposits 446,246 - 456,109 - 456,109 Mortgage escrow funds 10,123 10,123 - - 10,123 Accrued interest payable 246 1 245 246 FHLB advances 106,089 - 110,937 - 110,937 Derivative liabilities - interest rate contracts 8,305 - 8,305 - 8,305 The methods of determining the fair value of assets and liabilities presented in the table above are consistent with our methodologies disclosed in the Company's Consolidated Financial Statements included in the Annual Report on Form 10-K. |
Regulatory Matters
Regulatory Matters | 9 Months Ended |
Mar. 31, 2021 | |
Banking And Thrift Other Disclosures [Abstract] | |
Regulatory Matters | Note 8. Regulatory Matters The following is a summary of the Bank’s actual capital amounts and ratios as of March 31, 2021 and June 30, 2020, compared to the required ratios for minimum capital adequacy and for classification as well capitalized (dollars in thousands). To Be Well Capitalized For Capital Under Prompt Adequacy Corrective Action Bank Actual Purposes Provisions Amount Ratio Amount Ratio Amount Ratio March 31, 2021 Leverage (Tier 1) $ 230,237 12.8 % $ 72,197 4.0 % $ 90,247 5.0 % Risk-based: Common Tier 1 230,237 17.7 58,462 4.5 84,445 6.5 Tier 1 230,237 17.7 77,950 6.0 103,933 8.0 Total 238,102 18.3 103,933 8.0 129,916 10.0 June 30, 2020 Leverage (Tier 1) $ 220,310 12.5 % $ 70,432 4.0 % $ 88,040 5.0 % Risk-based: Common Tier 1 220,310 17.0 58,389 4.5 84,339 6.5 Tier 1 220,310 17.0 77,852 6.0 103,802 8.0 Total 228,949 17.0 103,802 8.0 129,753 10.0 In addition to the ratios above, the Basel III Capital Rules have established that community banking institutions must maintain a capital conservation buffer of common equity Tier 1 capital in an amount greater than 2.5% of total risk-weighted assets to avoid being subject to limitations on capital distributions and discretionary bonus payments to executive officers. Management believes that as of March 31, 2021 and June 30, 2020, the Bank met all capital adequacy requirements to which it was subject, including the capital conservation buffer of 2.5%, as of March 31, 2021 and June 30, 2020, respectively. Further, the most recent FDIC notification categorized the Bank as a well-capitalized institution under the prompt corrective action regulations. There have been no conditions or events since that notification that management believes have changed the Bank’s capital classification. |
Earnings Per Share ("EPS")
Earnings Per Share ("EPS") | 9 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Earnings Per Share ("EPS") | Note 9. Earnings Per Share (“EPS”) Basic EPS is calculated by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is calculated in a similar matter, except that the denominator includes the number of additional common shares that would have been outstanding if potentially dilutive common shares were issued using the treasury stock method. Dilutive financial instruments include stock options and unvested restricted stock. The following table provides factors used in the earnings per share computation. Three Months Ended March 31, Nine Months Ended March 31, 2021 2020 2021 2020 (amounts in thousands, except share and per share data) Net income applicable to common stock $ 3,592 $ 1,217 $ 9,014 $ 6,399 Average number of common shares outstanding 15,684,763 16,587,563 16,022,046 16,927,496 Less: Average unallocated ESOP shares (1,053,641 ) (1,150,390 ) (1,077,949 ) (1,174,787 ) Average number of common shares outstanding used to calculate basic earnings per common share 14,631,122 15,437,173 14,944,097 15,752,709 Effect of equity-based awards 1,220 10,044 567 61,613 Average number of common shares outstanding used to calculate diluted earnings per common share 14,632,342 15,447,217 14,944,664 15,814,322 Earnings per common share: Basic $ 0.25 $ 0.08 $ 0.60 $ 0.41 Diluted $ 0.25 $ 0.08 $ 0.60 $ 0.40 Stock options for 1,323,334 and 1,338,000 shares of common stock were not considered in computing diluted earnings per common share for the three and nine months ended March 31, 2021, respectively, because they were antidilutive. Stock options for 1,339,293 shares of common stock were not considered in computing diluted earnings per common share for the three and nine months ended March 31, 2020 |
Derivatives and Hedging
Derivatives and Hedging | 9 Months Ended |
Mar. 31, 2021 | |
Derivative Instruments And Hedging Activities Disclosure [Abstract] | |
Derivatives and Hedging | Note 10. Derivatives and Hedging Derivatives not designated as hedges may be used to manage the Company’s exposure to interest rate movements or to provide service to customers. The Company executes interest rate swaps with commercial lending customers to facilitate their respective risk management strategies. These interest rate swaps with customers are simultaneously offset by interest rate swaps that the Company executes with a third party in order to minimize the net risk exposure resulting from such transactions. The Company presents interest rate swap assets and liabilities in other assets and other liabilities, respectively, in the Consolidated Balance Sheets. These interest rate swap agreements do not qualify for hedge accounting treatment, and therefore changes in fair value are reported in current period earnings. The following table presents summary information about the interest rate swaps as of March 31, 2021 and June 30, 2020. March 31, June 30, 2021 2020 (dollars in thousands) Notional amounts $ 183,571 $ 159,242 Weighted average pay rates 2.55 % 2.54 % Weighted average receive rates 2.55 % 2.54 % Weighted average maturity 8.71 years 9.31 years Fair value of combined interest rate swaps $ - $ - |
Revenue From Contracts With Cus
Revenue From Contracts With Customers | 9 Months Ended |
Mar. 31, 2021 | |
Revenue From Contract With Customer [Abstract] | |
Revenue From Contracts With Customers | Note 11. Revenue From Contracts With Customers In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. The Company applies the following five steps to properly recognize revenue: 1. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to performance obligations in the contract. 5. Recognize revenue when (or as) the Company satisfies a performance obligation. The following table presents summary information about sources of revenue from contracts with customers for the periods indicated. Three Months Ended March 31, Nine Months Ended March 31, 2021 2020 2021 2020 (in thousands) Noninterest income: Service charges on deposits $ 173 $ 236 $ 531 $ 737 Interchange fees 128 95 392 324 Other (1) 52 35 115 109 Fees and service charges 353 366 1,038 1,170 Bank-owned life insurance (1) 120 128 381 399 Swap income (1) - - 367 170 Gain on sale of securities, net (1) 113 38 113 38 Net gain on sale of foreclosed real estate - 49 - 87 Other (1) 6 (1 ) 30 28 Other noninterest income 6 48 30 115 Total noninterest income $ 592 $ 580 $ 1,929 $ 1,892 (1) Fees and Service Charges on Deposit Accounts . The Company earns fees from its deposit customers for transaction-based, account maintenance, and overdraft services. Transaction-based fees, which include services such as ATM use fees, stop payments, statement rendering, and ACH fees, are recognized at the time the transaction is executed as that is the point in time the Company fulfills the customer’s request. Account maintenance fees, which relate primarily to monthly maintenance, are earned over the course of the month, representing the period over which the Company satisfied the performance obligation. Overdraft fees are recognized at the point in time that the overdraft occurs. Service charges on deposits are withdrawn from the customer’s account balance. Interchange Income . The Company earns interchange fees from debit cardholder transactions conducted through various payment networks. Interchange fees from cardholder transactions represent a percentage of the underlying transaction value and are recognized daily, concurrently with the transaction processing services provided to the cardholder. Gain on Sales of Foreclosed Real Estate . The Company records a gain or loss from the sale of foreclosed real estate when control of the property transfers to the buyer, which generally occurs at the time of an executed deed. When the Company finances the sale of foreclosed real estate to the buyer, the Company assesses whether the buyer is committed to perform their obligations under the contract and whether collectability of the transaction price is probable. Once these criteria are met, the foreclosed real estate asset is derecognized and the gain or loss on sale is recorded upon the transfer of control of the property to the buyer. In determining the gain or loss on the sale, the Company adjusts the transaction price and related gain (loss) on sale if a significant financing component is present. |
Share-Based Compensation
Share-Based Compensation | 9 Months Ended |
Mar. 31, 2021 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Share-Based Compensation | Note 12. Stock-Based Compensation On October 24, 2018, the Company’s shareholders approved the PCSB Financial Corporation 2018 Equity Incentive Plan (the “Plan”), which permits the grant of stock options and restricted stock and/or restricted stock units. The total number of shares that may be granted under the Plan is 2,543,115, of which 1,816,511 shares may be granted as stock options and 726,604 shares may be granted as restricted stock and restricted stock units. Total compensation cost that has been charged against income for the Plan was $809,000 and $2.5 million for the three and nine months ended March 31, 2021, and $829,000 and $2.5 million for the three and nine months ended March 31, 2020, respectively. Restricted Stock Awards (“RSAs”) RSAs provide for the issuance of shares to both employees and non-employee directors. These awards generally vest over a 5-year period, with 20% vesting each year on the anniversary of the award. All awards were made at the fair value of common stock on the grant date. Compensation expense is recognized over the vesting period of the awards based on the fair value of the stock at grant date. The fair value of the stock was determined to be the closing price of the stock on the NASDAQ exchange. Total shares available for grant under the Plan are 726,604, of which 541,467 shares were granted as of March 31, 2021. The following table presents a summary of RSA activity during the period ended March 31, 2021. Number of Shares Weighted-Average Grant Date Fair Value Unvested granted shares outstanding at July 1, 2020 437,737 $ 19.02 Shares granted 3,000 12.34 Shares vested (109,439 ) 19.02 Shares forfeited (8,718 ) 19.40 Unvested granted shares at March 31, 2021 322,580 $ 18.95 As of March 31, 2021, there was $5.5 million of total unrecognized compensation cost related to non-vested shares granted under the Plan. The cost is expected to be recognized over a weighted-average period of 2.7 years. Stock Option Awards Stock options awarded to employees under the Plan are considered incentive stock options (ISOs), up to applicable limits. Option awards are generally granted with an exercise price equal to the market price of the Company’s common stock at the date of grant. Those issued to non-employee directors, as well as those exceeding ISO limitations, are considered non-qualified stock options (NQSOs). Options generally vest over a 5-year period, with 20% vesting each year on the anniversary of the award, however, may not vest more rapidly than over a three-year The fair value of each option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model that uses the assumptions noted in the following table. Expected volatilities are based on the historical volatilities of a peer group of publicly traded financial institutions. The expected term of options granted is based on the simplified “mid-point” approach which utilizes the weighted average vesting period and contractual term. The risk-free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant. The fair value of options granted during the three and nine months ended March 31, 2021, was determined using the following weighted-average assumptions as of grant date. Risk-free interest rate 0.39 % Expected term (in years) 6.25 Expected stock price volatility 35.75 % Dividend yield 1.30 % Weighted average fair value of options granted $ 3.72 Total options available for grant under the Plan are 1,816,511, of which 1,308,963 options were granted as of March 31, 2021 . Number of Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Years Aggregate Intrinsic Value (dollars in thousands, except share and per share data) Options outstanding at July 1, 2020 1,339,293 $ 19.04 $ - Options granted 6,000 12.34 Options expired (14,532 ) 19.40 Options forfeited (21,798 ) 19.40 Options exercised - - Options outstanding at March 31, 2021 1,308,963 $ 19.00 7.6 $ 26 Exercisable at March 31, 2021 521,185 $ 19.03 7.6 $ - As of March 31, 2021, there was $3.2 million of total unrecognized compensation cost related to non-vested stock options granted under the Plan. The cost is expected to be recognized over a weighted-average period of 2.7 years. |
Leases
Leases | 9 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Leases | Note 13. Leases As of March 31, 2021, the Company leases real estate for eleven branch offices and one administrative office, including its corporate headquarters, under various operating lease agreements. The Company’s leases have maturities which range from 2022 to 2041, some of which include lessee options to extend the lease term. The weighted average remaining life of the lease terms for these leases was 9.62 years as of March 31, 2021. The operating lease asset and lease liability are determined at the commencement date of the lease based on the present value of the lease payments. As most of our leases do not provide an implicit rate, the Company used its incremental borrowing rate, the rate of interest to borrow on a collateralized basis for a similar term, at the lease commencement date. The Company utilized a weighted average discount rate of 2.37% in determining the lease liability as of March 31, 2021. The Company made a policy election to exclude the recognition requirements of ASC 842 to short-term leases, those leases with original terms of 12 months or less. Short-term lease payments are recognized in the income statement on a straight-line basis over the lease term. The Company had no short-term lease cost for the three or nine months ended March 31, 2021 or 2020. Certain leases may include one or more options to renew. The exercise of lease renewal options is typically at the Company’s discretion and are included in the operating lease liability if it is reasonably certain that the renewal option will be exercised. Certain real estate leases may contain lease and non-lease components, such as common area maintenance charges, real estate taxes, and insurance, which are generally accounted for separately and are not included in the measurement of the lease liability since they are generally able to be segregated. The Company does not sublease any of its leased properties. There were no sale and leaseback transactions, leveraged leases or lease transactions with related parties during the three or nine months ended March 3 1 , 20 2 1 or 20 20 . Total operating lease cost was $501,000 and $1.5 million for both the three and nine months ended March 31, 2021 and 2020, respectively, and is included in occupancy and equipment expense. The right-of-use asset, included in premises and equipment, net, was $10.1 million and the corresponding lease liability, included in other liabilities was $10.4 million as of March 31, 2021. Future minimum lease payments for the fiscal years ending June 30 and a reconciliation of undiscounted lease cash flows and the lease liability recognized in the consolidated balance sheet as of March 31, 2021 is shown below: (dollars in thousands) 2021 $ 507 2022 2,027 2023 1,940 2024 1,569 2025 1,276 Thereafter 4,550 Total future minimum lease payments (undiscounted) 11,869 Discounting effect on cash flows (1,502 ) Lease liability (discounted) $ 10,367 |
Basis of Presentation (Policies
Basis of Presentation (Policies) | 9 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Nature of Operations | Nature of Operations PCSB Bank is a community-oriented financial institution that provides financial services to individuals and businesses within its market area of Putnam, Southern Dutchess, Rockland and Westchester Counties in New York. The Bank is a state-chartered commercial bank, and its deposits are insured up to applicable limits by the Deposit Insurance Fund of the Federal Deposit Insurance Corporation (“FDIC”). The Bank’s primary regulators are the FDIC and the NYSDFS. |
Basis of Presentation | Basis of Presentation The unaudited consolidated financial statements contained herein reflect all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. Such adjustments are the only adjustments reflected in the consolidated financial statements contained herein. The results of operations for the current period presented are not necessarily indicative of the results of operations that may be expected for the entire current fiscal year. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The accompanying unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended June 30, 2020, included in the Company's Annual Report on Form 10-K. Certain prior period amounts have been reclassified to conform to the current presentation. Reclassifications had no effect on prior period net income or equity. |
Risks and Uncertainties | Risks and Uncertainties: The COVID-19 pandemic has created extensive disruptions to the global and U.S. economies and to the lives of individuals throughout the world. The New York City Metropolitan area and environs have had one of the highest incidences of COVID-19 in the nation, and the neighboring Tri-State area of New Jersey and Connecticut also has been particularly affected by COVID-19. Governments, businesses, and the public are taking unprecedented actions to contain the spread of COVID-19 and to mitigate its effects, including quarantines, travel bans, shelter-in-place orders, closures of businesses and schools, fiscal and monetary stimulus, and legislation designed to deliver financial aid and other relief. While the scope, duration, and full effects of COVID-19 continue to evolve and are not fully known, the pandemic and the efforts to contain it have disrupted global economic activity, adversely affected the functioning of financial markets, impacted market interest rates, increased economic and market uncertainty, and disrupted trade and supply chains. The ultimate financial impact of the pandemic is unknown at this time. However, if these actions are sustained, it may continue to adversely impact several industries within our geographic footprint and impair the ability of the Company’s customers to fulfill their contractual obligations to the Company. This could cause the Company to experience a material adverse effect on our business operations, asset valuations, financial condition, and results of operations. Material adverse impacts may include all or a combination of valuation impairments of the Company’s intangible assets, investments, loans, or deferred tax assets. It is reasonably possible that the Company’s allowance for loan losses as of March 31, 2021 will change in the near term and could result in a material change to the Company’s provision for loan losses, earnings and capital. |
Use of Estimates | Use of Estimates |
Recent Accounting Pronouncements | The pronouncements discussed below are not intended to be an all-inclusive list, but rather only those pronouncements that the Company has determined could potentially have a material impact on our financial position, results of operations or disclosures. There were no accounting standards adopted in the current period. Future Application of Accounting Pronouncements Previously Issued In June 2016, the FASB issued ASU 2016-13 “Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 affects entities holding financial assets that are not accounted for at fair value through net income, including loans, debt securities, and other financial assets. The ASU requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected by recording an allowance for current expected credit losses. In October 2019, the FASB unanimously voted to delay the implementation of the standard for three years for certain companies, including small reporting companies (as defined by the SEC), non-SEC public companies and private companies. The Company currently qualifies as a small reporting company and is subject to the delayed implementation. Therefore, t he amendments in this update will be effective for the Company for the fiscal year beginning on July 1, 2023, including interim periods within that fiscal year. The Company is actively working through the provisions of the Update. Management has established a steering committee which is identifying the methodologies and the additional data requirements necessary to implement the Update and has engaged a third-party software service provider to assist in the Company's implementation. Management is currently evaluating the impact that ASU 2016-13 will have on the Company’s consolidated financial position, results of operations and disclosures. |
Investment Securities (Tables)
Investment Securities (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Investments Debt And Equity Securities [Abstract] | |
Schedule of Amortized Cost, Gross Unrealized/Unrecognized Gains and Losses and Fair Value of Available for Sale and Held to Maturity Debt Securities | The amortized cost, gross unrealized/unrecognized gains and losses and fair value of available for sale and held to maturity debt securities at March 31, 2021 and June 30, 2020 were as follows: March 31, 2021 Amortized Gross Unrealized/Unrecognized Fair Cost Gains Losses Value (in thousands) Available for sale: U.S. Government and agency obligations $ 1,000 $ 4 $ - $ 1,004 Corporate 8,020 85 - 8,105 State and municipal 7,041 33 (210 ) 6,864 Mortgage-backed securities – residential 21,643 279 (285 ) 21,637 Total available for sale $ 37,704 $ 401 $ (495 ) $ 37,610 Held to maturity: U.S. Government and agency obligations $ 43,493 $ 261 $ (91 ) $ 43,663 Corporate 43,612 1,171 (127 ) 44,656 State and municipal 41,356 207 (843 ) 40,720 Mortgage-backed securities – residential 83,862 3,058 (113 ) 86,807 Mortgage-backed securities – collateralized mortgage obligations 45,260 935 (138 ) 46,057 Mortgage-backed securities – commercial 52,109 587 (625 ) 52,071 Total held to maturity $ 309,692 $ 6,219 $ (1,937 ) $ 313,974 June 30, 2020 Amortized Gross Unrealized/Unrecognized Fair Cost Gains Losses Value (in thousands) Available for sale: U.S. Government and agency obligations $ 11,002 $ 47 $ - $ 11,049 Corporate 5,038 82 - 5,120 Mortgage-backed securities – residential 20,844 428 (15 ) 21,257 Total available for sale $ 36,884 $ 557 $ (15 ) $ 37,426 Held to maturity: U.S. Government and agency obligations $ 42,001 $ 454 $ (5 ) $ 42,450 Corporate 43,634 142 (1,459 ) 42,317 State and municipal 9,156 190 (51 ) 9,295 Mortgage-backed securities – residential 117,160 4,291 (17 ) 121,434 Mortgage-backed securities – collateralized mortgage obligations 45,047 1,487 (31 ) 46,503 Mortgage-backed securities – commercial 18,774 724 - 19,498 Total held to maturity $ 275,772 $ 7,288 $ (1,563 ) $ 281,497 |
Fair Value and Carrying Amount of Debt Securities by Contractual Maturity | The following table presents the fair value and carrying amount of debt securities at March 31, 2021, by contractual maturity (in thousands). Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date, primarily mortgage-backed securities, are shown separately. Held to maturity Available for sale Carrying Fair Amortized Fair Amount Value Cost Value 1 year or less $ 6,035 $ 6,084 $ 4,020 $ 4,076 1 to 5 years 48,159 48,381 2,000 2,017 5 to 10 years 33,702 34,645 3,000 3,017 over 10 years 36,638 35,856 7,041 6,863 Mortgage-backed securities and other 185,158 189,008 21,643 21,637 Total $ 309,692 $ 313,974 $ 37,704 $ 37,610 |
Investment Securities with Fair Value and Unrealized Losses | The following table provides information regarding investment securities with unrealized/unrecognized losses, aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position at March 31, 2021 and June 30, 2020 March 31, 2021 Less than 12 months 12 months or greater Total Unrealized/ Unrealized/ Unrealized/ Fair Unrecognized Fair Unrecognized Fair Unrecognized Value Loss Value Loss Value Loss (in thousands) Available for sale: State and municipal $ 4,790 $ (210 ) $ - $ - $ 4,790 $ (210 ) Mortgage-backed securities – residential 9,852 (274 ) 1,365 (11 ) 11,217 (285 ) Total available for sale $ 14,642 $ (484 ) $ 1,365 $ (11 ) $ 16,007 $ (495 ) Held to maturity: U.S. Government and agency obligations $ 11,403 $ (91 ) $ - $ - $ 11,403 $ (91 ) Corporate 2,481 (18 ) 14,969 (109 ) 17,450 (127 ) State and municipal 28,818 (843 ) - - 28,818 (843 ) Mortgage-backed securities – residential 7,805 (113 ) - - 7,805 (113 ) Mortgage-backed securities – collateralized mortgage obligations 16,541 (138 ) - - 16,541 (138 ) Mortgage-backed securities – commercial 24,315 (625 ) - - 24,315 (625 ) Total held to maturity $ 91,363 $ (1,828 ) $ 14,969 $ (109 ) $ 106,332 $ (1,937 ) June 30, 2020 Less than 12 months 12 months or greater Total Unrealized/ Unrealized/ Unrealized/ Fair Unrecognized Fair Unrecognized Fair Unrecognized Value Loss Value Loss Value Loss (in thousands) Available for sale Mortgage-backed securities – residential $ 1,450 $ (15 ) $ - $ - $ 1,450 $ (15 ) Total available for sale $ 1,450 $ (15 ) $ - $ - $ 1,450 $ (15 ) Held to maturity U.S. Government and agency obligations $ 11,995 $ (5 ) $ - $ - $ 11,995 $ (5 ) Corporate 25,615 (1,004 ) 12,045 (455 ) 37,660 (1,459 ) State and municipal 5,136 (51 ) - - 5,136 (51 ) Mortgage-backed securities – residential 5,130 (17 ) - - 5,130 (17 ) Mortgage-backed securities – collateralized mortgage obligations 2,627 (31 ) - - 2,627 (31 ) Total held to maturity $ 50,503 $ (1,108 ) $ 12,045 $ (455 ) $ 62,548 $ (1,563 ) |
Loans Receivable (Tables)
Loans Receivable (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Summary of Loans Receivable | Loans receivable are summarized as follows (in thousands): March 31, June 30, 2021 2020 Mortgage loans: Residential $ 229,008 $ 255,382 Commercial 831,162 807,106 Construction 10,047 11,053 Net deferred loan origination costs 365 739 Total mortgage loans 1,070,582 1,074,280 Commercial and consumer loans: Commercial loans 171,314 164,257 Home equity lines of credit 27,211 29,838 Consumer and overdrafts 269 481 Net deferred loan origination costs (356 ) 730 Total commercial and consumer loans 198,438 195,306 Total loans receivable 1,269,020 1,269,586 Allowance for loan losses (7,865 ) (8,639 ) Loans receivable, net $ 1,261,155 $ 1,260,947 |
Summary of Activity in Allowance for Loan Losses by Portfolio Segment | The following tables present the activity in the allowance for loan losses by portfolio segment for the three and nine months ended March 31, 2021 and 2020 (in thousands): Three Months Ended March 31, 2021 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 334 $ (4 ) $ - $ 2 $ 332 Commercial mortgages 6,872 (354 ) - - 6,518 Construction 205 (103 ) - - 102 Commercial loans 1,201 (437 ) (21 ) 105 848 Home equity lines of credit 61 (1 ) - 2 62 Consumer and overdrafts 4 5 (6 ) - 3 Total $ 8,677 $ (894 ) $ (27 ) $ 109 $ 7,865 Three Months Ended March 31, 2020 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 352 $ 102 $ - $ 3 $ 457 Commercial mortgages 4,568 1,099 - 125 5,792 Construction 273 173 - - 446 Commercial loans 953 600 - - 1,553 Home equity lines of credit 60 23 - 2 85 Consumer and overdrafts 10 11 (9 ) 1 13 Total $ 6,216 $ 2,008 $ (9 ) $ 131 $ 8,346 Nine Months Ended March 31, 2021 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 373 $ (49 ) $ - $ 8 $ 332 Commercial mortgages 6,913 (395 ) - - 6,518 Construction 165 (63 ) - - 102 Commercial loans 1,124 (187 ) (245 ) 156 848 Home equity lines of credit 60 (4 ) - 6 62 Consumer and installment loans 4 20 (23 ) 2 3 Total $ 8,639 $ (678 ) $ (268 ) $ 172 $ 7,865 Nine Months Ended March 31, 2020 Beginning Allowance Provision (benefit) Charge-offs Recoveries Ending Allowance Residential mortgages $ 446 $ 34 $ (31 ) $ 8 $ 457 Commercial mortgages 3,853 1,814 - 125 5,792 Construction 159 287 - - 446 Commercial loans 1,130 573 (150 ) - 1,553 Home equity lines of credit 65 10 - 10 85 Consumer and installment loans 11 37 (42 ) 7 13 Total $ 5,664 $ 2,755 $ (223 ) $ 150 $ 8,346 |
Summary of Balance in Allowance for Loan Losses and Recorded investment in Loans by Portfolio Segment, and Based on Impairment Method | The following tables present the balance in the allowance for loan losses and the recorded investment in loans, excluding net deferred fees and accrued interest, by portfolio segment, and based on impairment method as of March 31, 2021 and June 30, 2020 (in thousands): March 31, 2021 Loans Allowance for Loan Losses Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Residential mortgages $ 2,238 $ 226,049 $ 721 $ 229,008 $ 114 $ 218 $ - $ 332 Commercial mortgages - 830,264 898 831,162 - 6,518 - 6,518 Construction - 10,047 - 10,047 - 102 - 102 Commercial loans 1,739 169,575 - 171,314 - 848 - 848 Home equity lines of credit 410 26,674 127 27,211 9 53 - 62 Consumer and overdrafts - 269 - 269 - 3 - 3 Total $ 4,387 $ 1,262,878 $ 1,746 $ 1,269,011 $ 123 $ 7,742 $ - $ 7,865 June 30, 2020 Loans Allowance for Loan Losses Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Individually Evaluated for Impairment Collectively Evaluated for Impairment Acquired With Deteriorated Credit Quality Total Residential mortgages $ 2,448 $ 252,195 $ 739 $ 255,382 $ 118 $ 255 $ - $ 373 Commercial mortgages - 806,224 882 807,106 - 6,913 - 6,913 Construction - 11,053 - 11,053 - 165 - 165 Commercial loans 1,921 162,336 - 164,257 1 1,123 - 1,124 Home equity lines of credit 350 29,349 139 29,838 4 56 - 60 Consumer and overdrafts - 481 - 481 - 4 - 4 Total $ 4,719 $ 1,261,638 $ 1,760 $ 1,268,117 $ 123 $ 8,516 $ - $ 8,639 |
Summary of Loans Individually Evaluated for Impairment (Excluding Loans Acquired with Deteriorated Credit Quality) by Portfolio Segment | The following tables present information related to loans individually evaluated for impairment (excluding loans acquired with deteriorated credit quality) by portfolio segment as of March 31, 2021 and June 30, 2020 (in thousands): March 31, 2021 June 30, 2020 Unpaid Principal Balance Recorded Investment Allowance for Loan Losses Unpaid Principal Balance Recorded Investment Allowance for Loan Losses With no related allowance recorded: Residential mortgages $ 1,926 $ 1,812 $ - $ 2,123 $ 2,013 $ - Commercial loans 1,909 1,739 - 2,067 1,897 - Home equity lines of credit 358 379 - 326 339 - With an allowance recorded: Residential mortgages 365 426 114 372 435 118 Commercial loans - - - 24 24 1 Home equity lines of credit 31 31 9 11 11 4 Total $ 4,589 $ 4,387 $ 123 $ 4,923 $ 4,719 $ 123 |
Summary of Average Recorded Investment and Interest Income Recognized on Loans Individually Evaluated for Impairment, by Portfolio Segment | The tables below present the average recorded investment and interest income recognized on loans individually evaluated for impairment, by portfolio segment, for the three and nine months ended March 31, 2021 and 2020 (in thousands): Three months ended Three months ended March 31, 2021 March 31, 2020 Average Recorded Investment Interest Income Recognized Average Recorded Investment Interest Income Recognized With no related allowance recorded: Residential mortgages $ 1,822 $ 7 $ 2,060 $ 13 Commercial mortgages - - 485 9 Commercial loans 1,749 47 1,932 51 Home equity lines of credit 379 - 403 7 With an allowance recorded: Residential mortgages 427 4 435 4 Commercial loans - - 38 - Home equity lines of credit 30 - 11 (6 ) Total $ 4,407 $ 58 $ 5,364 $ 78 Nine Months Ended Nine Months Ended March 31, 2021 March 31, 2020 Average Recorded Investment Interest Income Recognized Average Recorded Investment Interest Income Recognized With no related allowance recorded: Residential mortgages $ 1,905 $ 27 $ 2,050 $ 40 Commercial mortgages - - 946 149 Commercial loans 1,786 144 2,015 154 Home equity lines of credit 384 1 574 20 With an allowance recorded: Residential mortgages 429 11 437 11 Commercial loans - - 42 1 Home equity lines of credit 24 - 11 - Total $ 4,528 $ 183 $ 6,075 $ 375 |
Nonaccrual Loans and in Loans Past Due over 90 Days Still on Accrual Status by Portfolio Segment | The following table presents the recorded investment in nonaccrual loans and in loans past due over 90 days and still on accrual status, by portfolio segment, as of March 31, 2021 and June 30, 2020 (in thousands): Loans Past Due Over 90 Days Nonaccrual and Still Accruing March 31, June 30, March 31, June 30, 2021 2020 2021 2020 Residential mortgages $ 1,267 $ 1,457 $ - $ - Commercial mortgages - - 408 - Home equity lines of credit 379 338 - - Total $ 1,646 $ 1,795 $ 408 $ - |
Aging of Recorded Investment in Past Due Loans by Portfolio Segment | The following tables present the aging of the recorded investment in past due loans by portfolio segment as of March 31, 2021 and June 30, 2020 (in thousands): March 31, 2021 30-59 60-89 90 Days or Days Past Days Past More Past Total Past Due Due Due Due Current (1) Total Residential mortgages $ - $ - $ 939 $ 939 $ 228,069 $ 229,008 Commercial mortgages - - 408 408 830,754 831,162 Construction - - - - 10,047 10,047 Commercial loans 54 226 - 280 171,034 171,314 Home equity lines of credit - - 379 379 26,832 27,211 Consumer and overdrafts - - - - 269 269 Total $ 54 $ 226 $ 1,726 $ 2,006 $ 1,267,005 $ 1,269,011 June 30, 2020 30-59 60-89 90 Days or Days Past Days Past More Past Total Past Due Due Due Due Current (1) Total Residential mortgages $ 495 $ 10 $ 806 $ 1,311 $ 254,071 $ 255,382 Commercial mortgages - - - - 807,106 807,106 Construction - - - - 11,053 11,053 Commercial loans 76 - - 76 164,181 164,257 Home equity lines of credit 44 - 338 382 29,456 29,838 Consumer and overdrafts - - - - 481 481 Total $ 615 $ 10 $ 1,144 $ 1,769 $ 1,266,348 $ 1,268,117 (1) As of March 31, 2021 and June 30, 2020, loans on a COVID-19-related payment deferral of $34.4 million and $200.6 million, respectively, are considered current. |
Summary of Risk Category of Loans by Portfolio Segment | Based on the most recent analysis performed, the risk category of loans by portfolio segment is as follows (in thousands): March 31, 2021 Pass Special Mention Substandard Total Residential mortgages $ 224,725 $ 2,358 $ 1,925 $ 229,008 Commercial mortgages 814,173 1,627 15,362 831,162 Construction 10,047 - - 10,047 Commercial loans 167,309 94 3,911 171,314 Home equity lines of credit 25,870 902 439 27,211 Consumer and overdrafts 269 - - 269 Total $ 1,242,393 $ 4,981 $ 21,637 $ 1,269,011 June 30, 2020 Pass Special Mention Substandard Total Residential mortgages $ 252,604 $ 687 $ 2,091 $ 255,382 Commercial mortgages 803,048 3,176 882 807,106 Construction 11,053 - - 11,053 Commercial loans 160,137 201 3,919 164,257 Home equity lines of credit 28,894 498 446 29,838 Consumer and overdrafts 481 - - 481 Total $ 1,256,217 $ 4,562 $ 7,338 $ 1,268,117 |
Schedule of Carrying Amount of Purchased Credit Impaired Loans | The carrying amount of those loans as of March 31, 2021 and June 30, 2020 is as follows (in thousands): March 31, June 30, 2021 2020 Residential mortgages $ 721 $ 739 Commercial mortgages 898 882 Home equity lines of credit 127 139 Carrying amount, net of allowance of $0 $ 1,746 $ 1,760 |
Summary of Accretable Yield, or Income Expected to be Collected for Acquired Loans | Accretable yield, or income expected to be collected, for acquired loans is as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2021 2020 2021 2020 Beginning balance $ 147 $ 174 $ 156 $ 192 New loans acquired - - - - Accretion income (9 ) (9 ) (18 ) (27 ) Reclassification from non-accretable difference - - - - Disposals - - - - Ending balance $ 138 $ 165 $ 138 $ 165 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Equity [Abstract] | |
Summary of Accumulated Other Comprehensive Income (Loss) | The following is a summary of the accumulated other comprehensive income (loss) balances, net of tax (in thousands): Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at January 1, 2021 $ 413 $ (6,153 ) $ (205 ) $ (5,945 ) Other comprehensive loss before reclassifications (565 ) - - (565 ) Amounts reclassified from accumulated other comprehensive income (52 ) 305 14 267 Less tax effect 129 (64 ) (2 ) 63 Net other comprehensive (loss) income (488 ) 241 12 (235 ) Balance at March 31, 2021 $ (75 ) $ (5,912 ) $ (193 ) $ (6,180 ) Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at January 1, 2020 $ (34 ) $ (4,207 ) $ (233 ) $ (4,474 ) Other comprehensive income before reclassifications 186 - - 186 Amounts reclassified from accumulated other comprehensive income (20 ) 132 11 123 Less tax effect (35 ) (27 ) (3 ) (65 ) Net other comprehensive income 131 105 8 244 Balance at March 31, 2020 $ 97 $ (4,102 ) $ (225 ) $ (4,230 ) Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at July 1, 2020 $ 428 $ (6,605 ) $ (226 ) $ (6,403 ) Other comprehensive loss before reclassifications (584 ) - - (584 ) Amounts reclassified from accumulated other comprehensive income (52 ) 877 42 867 Tax effect 133 (184 ) (9 ) (60 ) Net other comprehensive (loss) income (503 ) 693 33 223 Balance at March 31, 2021 $ (75 ) $ (5,912 ) $ (193 ) $ (6,180 ) Net unrealized gain (loss) on available for sale securities Unrealized loss on pension benefits Unrealized loss on SERP benefits Total Balance at July 1, 2019 $ (209 ) $ (4,631 ) $ (250 ) $ (5,090 ) Other comprehensive income before reclassifications 406 - - 406 Amounts reclassified from accumulated other comprehensive income (20 ) 668 34 682 Tax effect (80 ) (139 ) (9 ) (228 ) Net other comprehensive income 306 529 25 860 Balance at March 31, 2020 $ 97 $ (4,102 ) $ (225 ) $ (4,230 ) |
Post-Retirement Benefits (Table
Post-Retirement Benefits (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Compensation And Retirement Disclosure [Abstract] | |
Schedule of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Income | Net periodic benefit cost and other amounts recognized in other comprehensive income for the three and nine months ended March 31, 2021 and 2020 (in thousands): Three Months Ended Three Months Ended March 31, 2021 March 31, 2020 Defined Benefit Plan Supplemental Retirement Plans Defined Benefit Plan Supplemental Retirement Plans Service cost $ - $ 130 $ - $ 90 Interest cost 136 18 180 28 Expected return on plan assets (455 ) - (479 ) - Amortization of prior net loss 241 14 132 11 Settlement charges 65 - - - Net periodic (benefit) cost $ (13 ) $ 162 $ (167 ) $ 129 Nine Months Ended Nine Months Ended March 31, 2021 March 31, 2020 Defined Benefit Plan Supplemental Retirement Plan Defined Benefit Plan Supplemental Retirement Plan Service cost $ - $ 311 $ - $ 248 Interest cost 409 65 540 89 Expected return on plan assets (1,366 ) - (1,436 ) - Amortization of prior net loss 720 42 396 34 Settlement charges 158 - 272 - Net periodic (benefit) cost $ (79 ) $ 418 $ (228 ) $ 371 |
Shares Held by ESOP | Shares held by the ESOP include the following (dollars in thousands): March 31, 2021 June 30, 2020 Allocated to participants 402,362 327,206 Unearned 1,041,802 1,114,529 Total ESOP shares 1,444,164 1,441,735 Fair value of unearned shares $ 17,304 $ 14,132 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Summary of Assets and Liabilities Measured at Fair Value | Assets and liabilities measured at fair value are summarized below (in thousands): Fair Value Measurements Level 1 Level 2 Level 3 Total March 31, 2021 Measured on a recurring basis: Available for sale securities: U.S. Government and agency obligations $ - $ 1,004 $ - $ 1,004 Corporate - 8,105 - 8,105 State and municipal - 6,864 - 6,864 Mortgage-backed securities – residential - 21,637 - 21,637 Derivatives – interest rate contracts - 4,425 - 4,425 Total assets at fair value $ - $ 42,035 $ - $ 42,035 Derivatives – interest rate contracts $ - $ 4,425 $ - $ 4,425 Total liabilities at fair value $ - $ 4,425 $ - $ 4,425 Measured on a non-recurring basis: Impaired loans: Residential mortgages $ - $ - $ 312 $ 312 Home equity lines of credit - - 21 21 Total assets at fair value $ - $ - $ 333 $ 333 Fair Value Measurements Level 1 Level 2 Level 3 Total June 30, 2020 Measured on a recurring basis: Available for sale securities: U.S. Government and agency obligations $ - $ 11,049 $ - $ 11,049 Corporate - 5,120 - 5,120 Mortgage-backed securities – residential - 21,257 - 21,257 Derivatives – interest rate contracts - 8,305 - 8,305 Total assets at fair value $ - $ 45,731 $ - $ 45,731 Derivatives – interest rate contracts $ - $ 8,305 $ - $ 8,305 Total liabilities at fair value $ - $ 8,305 $ - $ 8,305 Measured on a non-recurring basis: Impaired loans: Residential mortgages $ - $ - $ 317 $ 317 Commercial loans - - 100 100 Home equity lines of credit - - 7 7 Total assets at fair value $ - $ - $ 424 $ 424 |
Summary of Quantitative Information about Level 3 Fair Value Measurements for Selected Financial Instruments Measured at Fair Value on Non-recurring Basis | The following tables present quantitative information about Level 3 fair value measurements for selected financial instruments measured at fair value on a non-recurring basis at March 31, 2021 and June 30, 2020 (dollars in thousands): Valuation Unobservable Range or Fair Value Technique(s) Input(s) Rate Used March 31, 2021 Impaired loans - residential mortgages $ 312 Discounted cash flow Discount rate 5.4% to 6.3% Impaired loans - home equity lines of credit 21 Discounted cash flow Discount rate 5.4% to 6.3% June 30, 2020 Impaired loans - residential mortgages $ 316 Discounted cash flow Discount rate 5.4% to 6.3% Impaired loans - home equity lines of credit 7 Discounted cash flow Discount rate 6.3% Impaired loans - commercial loans 100 Discounted cash flow Discount rate 6.8% to 7.5% |
Summary of Carrying Amounts and Estimated Fair Values of Bank's Financial Assets and Liabilities | The following is a summary of the carrying amounts and estimated fair values of the Company’s financial assets and liabilities, none of which are held for trading purposes (in thousands): Carrying Fair Value Measurements Amount Level 1 Level 2 Level 3 Total March 31, 2021 Financial assets: Cash and cash equivalents $ 169,314 $ 169,314 $ - $ - $ 169,314 Investment securities held to maturity 309,692 - 286,539 27,435 313,974 Investment securities available for sale 37,610 - 37,610 - 37,610 Loans receivable, net 1,261,155 - - 1,240,645 1,240,645 Accrued interest receivable 6,731 - 1,300 5,431 6,731 FHLB stock 5,854 N/A N/A N/A N/A Derivative assets - interest rate contracts 4,425 - 4,425 - 4,425 Financial liabilities: Demand, NOW, money market deposits and savings accounts 1,046,464 1,046,464 - - 1,046,464 Time deposits 407,826 - 414,737 - 414,737 Mortgage escrow funds 9,252 9,252 - - 9,252 Accrued interest payable 228 1 227 - 228 FHLB advances 95,991 - 99,550 - 99,550 Derivative liabilities - interest rate contracts 4,425 - 4,425 - 4,425 Carrying Fair Value Measurements Amount Level 1 Level 2 Level 3 Total June 30, 2020 Financial assets: Cash and cash equivalents $ 136,302 $ 136,302 $ - $ - $ 136,302 Investment securities held to maturity 275,772 - 276,847 4,650 281,497 Investment securities available for sale 37,426 - 37,426 - 37,426 Loans receivable, net 1,260,947 - - 1,240,440 1,240,440 Accrued interest receivable 6,880 - 997 5,883 6,880 FHLB stock 6,308 N/A N/A N/A N/A Derivative assets - interest rate contracts 8,305 - 8,305 - 8,305 Financial liabilities: Demand, NOW, money market deposits and savings accounts 926,989 926,989 - - 926,989 Time deposits 446,246 - 456,109 - 456,109 Mortgage escrow funds 10,123 10,123 - - 10,123 Accrued interest payable 246 1 245 246 FHLB advances 106,089 - 110,937 - 110,937 Derivative liabilities - interest rate contracts 8,305 - 8,305 - 8,305 |
Regulatory Matters (Tables)
Regulatory Matters (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Banking And Thrift Other Disclosures [Abstract] | |
Summary of Bank's Actual Capital Amounts and Ratios Compared to Required Ratios for Minimum Capital Adequacy and for Classification as Well Capitalized | The following is a summary of the Bank’s actual capital amounts and ratios as of March 31, 2021 and June 30, 2020, compared to the required ratios for minimum capital adequacy and for classification as well capitalized (dollars in thousands). To Be Well Capitalized For Capital Under Prompt Adequacy Corrective Action Bank Actual Purposes Provisions Amount Ratio Amount Ratio Amount Ratio March 31, 2021 Leverage (Tier 1) $ 230,237 12.8 % $ 72,197 4.0 % $ 90,247 5.0 % Risk-based: Common Tier 1 230,237 17.7 58,462 4.5 84,445 6.5 Tier 1 230,237 17.7 77,950 6.0 103,933 8.0 Total 238,102 18.3 103,933 8.0 129,916 10.0 June 30, 2020 Leverage (Tier 1) $ 220,310 12.5 % $ 70,432 4.0 % $ 88,040 5.0 % Risk-based: Common Tier 1 220,310 17.0 58,389 4.5 84,339 6.5 Tier 1 220,310 17.0 77,852 6.0 103,802 8.0 Total 228,949 17.0 103,802 8.0 129,753 10.0 |
Earnings Per Share ("EPS") (Tab
Earnings Per Share ("EPS") (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share | Three Months Ended March 31, Nine Months Ended March 31, 2021 2020 2021 2020 (amounts in thousands, except share and per share data) Net income applicable to common stock $ 3,592 $ 1,217 $ 9,014 $ 6,399 Average number of common shares outstanding 15,684,763 16,587,563 16,022,046 16,927,496 Less: Average unallocated ESOP shares (1,053,641 ) (1,150,390 ) (1,077,949 ) (1,174,787 ) Average number of common shares outstanding used to calculate basic earnings per common share 14,631,122 15,437,173 14,944,097 15,752,709 Effect of equity-based awards 1,220 10,044 567 61,613 Average number of common shares outstanding used to calculate diluted earnings per common share 14,632,342 15,447,217 14,944,664 15,814,322 Earnings per common share: Basic $ 0.25 $ 0.08 $ 0.60 $ 0.41 Diluted $ 0.25 $ 0.08 $ 0.60 $ 0.40 |
Derivatives and Hedging (Tables
Derivatives and Hedging (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Derivative Instruments And Hedging Activities Disclosure [Abstract] | |
Summary Information About Interest Rate Swaps | The following table presents summary information about the interest rate swaps as of March 31, 2021 and June 30, 2020. March 31, June 30, 2021 2020 (dollars in thousands) Notional amounts $ 183,571 $ 159,242 Weighted average pay rates 2.55 % 2.54 % Weighted average receive rates 2.55 % 2.54 % Weighted average maturity 8.71 years 9.31 years Fair value of combined interest rate swaps $ - $ - |
Revenue From Contracts With C_2
Revenue From Contracts With Customers (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Revenue From Contract With Customer [Abstract] | |
Summary of Sources of Revenue from Contracts with Customers | The following table presents summary information about sources of revenue from contracts with customers for the periods indicated. Three Months Ended March 31, Nine Months Ended March 31, 2021 2020 2021 2020 (in thousands) Noninterest income: Service charges on deposits $ 173 $ 236 $ 531 $ 737 Interchange fees 128 95 392 324 Other (1) 52 35 115 109 Fees and service charges 353 366 1,038 1,170 Bank-owned life insurance (1) 120 128 381 399 Swap income (1) - - 367 170 Gain on sale of securities, net (1) 113 38 113 38 Net gain on sale of foreclosed real estate - 49 - 87 Other (1) 6 (1 ) 30 28 Other noninterest income 6 48 30 115 Total noninterest income $ 592 $ 580 $ 1,929 $ 1,892 (1) |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Summary of RSA Activity | The following table presents a summary of RSA activity during the period ended March 31, 2021. Number of Shares Weighted-Average Grant Date Fair Value Unvested granted shares outstanding at July 1, 2020 437,737 $ 19.02 Shares granted 3,000 12.34 Shares vested (109,439 ) 19.02 Shares forfeited (8,718 ) 19.40 Unvested granted shares at March 31, 2021 322,580 $ 18.95 |
Summary of Fair Value of Options Granted Using Weighted-Average Assumptions as of Grant Date | The fair value of options granted during the three and nine months ended March 31, 2021, was determined using the following weighted-average assumptions as of grant date. Risk-free interest rate 0.39 % Expected term (in years) 6.25 Expected stock price volatility 35.75 % Dividend yield 1.30 % Weighted average fair value of options granted $ 3.72 |
Summary of Activity Related to Stock Options Granted under Plan | The following table presents a summary of activity related to stock options granted under the Plan, and changes during the period then ended: Number of Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Years Aggregate Intrinsic Value (dollars in thousands, except share and per share data) Options outstanding at July 1, 2020 1,339,293 $ 19.04 $ - Options granted 6,000 12.34 Options expired (14,532 ) 19.40 Options forfeited (21,798 ) 19.40 Options exercised - - Options outstanding at March 31, 2021 1,308,963 $ 19.00 7.6 $ 26 Exercisable at March 31, 2021 521,185 $ 19.03 7.6 $ - |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Schedule of Future Minimum Lease Payments | Future minimum lease payments for the fiscal years ending June 30 and a reconciliation of undiscounted lease cash flows and the lease liability recognized in the consolidated balance sheet as of March 31, 2021 is shown below: (dollars in thousands) 2021 $ 507 2022 2,027 2023 1,940 2024 1,569 2025 1,276 Thereafter 4,550 Total future minimum lease payments (undiscounted) 11,869 Discounting effect on cash flows (1,502 ) Lease liability (discounted) $ 10,367 |
Basis of Presentation - Additio
Basis of Presentation - Additional Information (Detail) | 9 Months Ended |
Mar. 31, 2021Subsidiary | |
Basis Of Presentation [Abstract] | |
Number of subsidiaries | 2 |
Investment Securities - Schedul
Investment Securities - Schedule of Amortized Cost, Gross Unrealized/Unrecognized Gains and Losses and Fair Value of Available for Sale and Held to Maturity Debt Securities (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Schedule of Investments [Line Items] | ||
Available for sale, Amortized Cost | $ 37,704 | $ 36,884 |
Available for sale, Gross Unrealized/Unrecognized Gains | 401 | 557 |
Available for sale, Gross Unrealized/Unrecognized Losses | (495) | (15) |
Available for sale, Fair Value | 37,610 | 37,426 |
Held to maturity, Amortized Cost | 309,692 | 275,772 |
Held to maturity, Gross Unrealized/Unrecognized Gains | 6,219 | 7,288 |
Held to maturity, Gross Unrealized/Unrecognized Losses | (1,937) | (1,563) |
Held to maturity, Fair Value | 313,974 | 281,497 |
U.S. Government and Agency Obligations [Member] | ||
Schedule of Investments [Line Items] | ||
Available for sale, Amortized Cost | 1,000 | 11,002 |
Available for sale, Gross Unrealized/Unrecognized Gains | 4 | 47 |
Available for sale, Fair Value | 1,004 | 11,049 |
Held to maturity, Amortized Cost | 43,493 | 42,001 |
Held to maturity, Gross Unrealized/Unrecognized Gains | 261 | 454 |
Held to maturity, Gross Unrealized/Unrecognized Losses | (91) | (5) |
Held to maturity, Fair Value | 43,663 | 42,450 |
Corporate [Member] | ||
Schedule of Investments [Line Items] | ||
Available for sale, Amortized Cost | 8,020 | 5,038 |
Available for sale, Gross Unrealized/Unrecognized Gains | 85 | 82 |
Available for sale, Fair Value | 8,105 | 5,120 |
Held to maturity, Amortized Cost | 43,612 | 43,634 |
Held to maturity, Gross Unrealized/Unrecognized Gains | 1,171 | 142 |
Held to maturity, Gross Unrealized/Unrecognized Losses | (127) | (1,459) |
Held to maturity, Fair Value | 44,656 | 42,317 |
State and Municipal [Member] | ||
Schedule of Investments [Line Items] | ||
Available for sale, Amortized Cost | 7,041 | |
Available for sale, Gross Unrealized/Unrecognized Gains | 33 | |
Available for sale, Gross Unrealized/Unrecognized Losses | (210) | |
Available for sale, Fair Value | 6,864 | |
Held to maturity, Amortized Cost | 41,356 | 9,156 |
Held to maturity, Gross Unrealized/Unrecognized Gains | 207 | 190 |
Held to maturity, Gross Unrealized/Unrecognized Losses | (843) | (51) |
Held to maturity, Fair Value | 40,720 | 9,295 |
Mortgage-backed Securities - Residential [Member] | ||
Schedule of Investments [Line Items] | ||
Available for sale, Amortized Cost | 21,643 | 20,844 |
Available for sale, Gross Unrealized/Unrecognized Gains | 279 | 428 |
Available for sale, Gross Unrealized/Unrecognized Losses | (285) | (15) |
Available for sale, Fair Value | 21,637 | 21,257 |
Held to maturity, Amortized Cost | 83,862 | 117,160 |
Held to maturity, Gross Unrealized/Unrecognized Gains | 3,058 | 4,291 |
Held to maturity, Gross Unrealized/Unrecognized Losses | (113) | (17) |
Held to maturity, Fair Value | 86,807 | 121,434 |
Mortgage-backed Securities - Collateralized Mortgage Obligations [Member] | ||
Schedule of Investments [Line Items] | ||
Held to maturity, Amortized Cost | 45,260 | 45,047 |
Held to maturity, Gross Unrealized/Unrecognized Gains | 935 | 1,487 |
Held to maturity, Gross Unrealized/Unrecognized Losses | (138) | (31) |
Held to maturity, Fair Value | 46,057 | 46,503 |
Mortgage-backed Securities - Commercial [Member] | ||
Schedule of Investments [Line Items] | ||
Held to maturity, Amortized Cost | 52,109 | 18,774 |
Held to maturity, Gross Unrealized/Unrecognized Gains | 587 | 724 |
Held to maturity, Gross Unrealized/Unrecognized Losses | (625) | |
Held to maturity, Fair Value | $ 52,071 | $ 19,498 |
Investment Securities - Additio
Investment Securities - Additional Information (Detail) | 3 Months Ended | 9 Months Ended | ||||
Mar. 31, 2021USD ($)Securityshares | Mar. 31, 2020USD ($) | Mar. 31, 2021USD ($)Securityshares | Mar. 31, 2020USD ($) | Jun. 30, 2020USD ($)Securityshares | ||
Investments Debt And Equity Securities [Abstract] | ||||||
Sale of investment securities | $ 5,000,000 | $ 4,700,000 | $ 5,000,000 | $ 4,700,000 | ||
Gross realized gains or losses on investment securities | [1] | 113,000 | 38,000 | 113,000 | 38,000 | |
Disposal of securities held to maturity | 1,600,000 | 426,000 | 1,600,000 | 426,000 | ||
Gross realized gains from sale of securities held to maturity | $ 61,000 | $ 17,000 | $ 61,000 | $ 17,000 | ||
Held to maturity substantial portion of principal outstanding percentage | 85.00% | 85.00% | ||||
Carrying amounts of securities pledged | $ 183,200,000 | $ 183,200,000 | $ 182,200,000 | |||
Total investment securities | $ 347,302,000 | $ 347,302,000 | $ 313,198,000 | |||
Number of securities in unrealized loss position | Security | 57 | 57 | ||||
Fair value of securities in unrealized loss position | $ 122,300,000 | $ 122,300,000 | ||||
Number of securities holding other than U.S. government and its agencies amount greater than 10% of shareholders equity | shares | 0 | 0 | 0 | |||
Other-than-temporarily impaired securities | Security | 0 | 0 | 0 | |||
[1] | Not within the scope of ASC 606 |
Investment Securities - Fair Va
Investment Securities - Fair Value and Carrying Amount of Debt Securities by Contractual Maturity (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Investments Debt And Equity Securities [Abstract] | ||
Held to maturity, carrying amount, 1 year or less | $ 6,035 | |
Held to maturity, carrying amount, 1 to 5 years | 48,159 | |
Held to maturity, carrying amount, 5 to 10 years | 33,702 | |
Held to maturity, carrying amount, over 10 years | 36,638 | |
Held to maturity, carrying amount, Mortgage-backed securities and other | 185,158 | |
Held to maturity, Amortized Cost | 309,692 | $ 275,772 |
Held to maturity, fair value, 1 year or less | 6,084 | |
Held to maturity, fair value, 1 to 5 years | 48,381 | |
Held to maturity, fair value, 5 to 10 years | 34,645 | |
Held to maturity, fair value, over 10 years | 35,856 | |
Held to maturity, fair value, Mortgage-backed securities and other | 189,008 | |
Held to maturity, fair value, Total | 313,974 | 281,497 |
Available for sale, amortized cost, 1 year or less | 4,020 | |
Available for sale, amortized cost, 1 to 5 years | 2,000 | |
Available for sale, amortized cost, 5 to 10 years | 3,000 | |
Available for sale, amortized cost, over 10 years | 7,041 | |
Available for sale, amortized cost, Mortgage-backed securities and other | 21,643 | |
Available for sale, Amortized Cost | 37,704 | 36,884 |
Available for sale, fair value, 1 year or less | 4,076 | |
Available for sale, fair value, 1 to 5 years | 2,017 | |
Available for sale, fair value, 5 to 10 years | 3,017 | |
Available for sale, fair value, over 10 years | 6,863 | |
Available for sale, fair value, Mortgage-backed securities and other | 21,637 | |
Available for sale, fair value, Total | $ 37,610 | $ 37,426 |
Investment Securities - Investm
Investment Securities - Investment Securities with Fair Value and Unrealized Losses (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Schedule of Investments [Line Items] | ||
Available for sale, Less than 12 months, Fair Value | $ 14,642 | $ 1,450 |
Available for sale, Less than 12 months, Unrealized/Unrecognized Loss | (484) | (15) |
Available for sale, 12 months or greater, Fair Value | 1,365 | |
Available for sale, 12 months or greater, Unrealized/Unrecognized Loss | (11) | |
Available for sale, Total, Fair Value | 16,007 | 1,450 |
Available for sale, Total, Unrealized/Unrecognized Loss | (495) | (15) |
Held to maturity, Less than 12 months, Fair Value | 91,363 | 50,503 |
Held to maturity, Less than 12 months, Unrealized/ Unrecognized Loss | (1,828) | (1,108) |
Held to maturity, 12 months or greater, Fair Value | 14,969 | 12,045 |
Held to maturity, 12 months or greater, Unrealized/ Unrecognized Loss | (109) | (455) |
Held to maturity, Total, Fair Value | 106,332 | 62,548 |
Held to maturity, Total, Unrealized/ Unrecognized Loss | (1,937) | (1,563) |
State and Municipal [Member] | ||
Schedule of Investments [Line Items] | ||
Available for sale, Less than 12 months, Fair Value | 4,790 | |
Available for sale, Less than 12 months, Unrealized/Unrecognized Loss | (210) | |
Available for sale, Total, Fair Value | 4,790 | |
Available for sale, Total, Unrealized/Unrecognized Loss | (210) | |
Held to maturity, Less than 12 months, Fair Value | 28,818 | 5,136 |
Held to maturity, Less than 12 months, Unrealized/ Unrecognized Loss | (843) | (51) |
Held to maturity, Total, Fair Value | 28,818 | 5,136 |
Held to maturity, Total, Unrealized/ Unrecognized Loss | (843) | (51) |
Mortgage-backed Securities - Residential [Member] | ||
Schedule of Investments [Line Items] | ||
Available for sale, Less than 12 months, Fair Value | 9,852 | 1,450 |
Available for sale, Less than 12 months, Unrealized/Unrecognized Loss | (274) | (15) |
Available for sale, 12 months or greater, Fair Value | 1,365 | |
Available for sale, 12 months or greater, Unrealized/Unrecognized Loss | (11) | |
Available for sale, Total, Fair Value | 11,217 | 1,450 |
Available for sale, Total, Unrealized/Unrecognized Loss | (285) | (15) |
Held to maturity, Less than 12 months, Fair Value | 7,805 | 5,130 |
Held to maturity, Less than 12 months, Unrealized/ Unrecognized Loss | (113) | (17) |
Held to maturity, Total, Fair Value | 7,805 | 5,130 |
Held to maturity, Total, Unrealized/ Unrecognized Loss | (113) | (17) |
U.S. Government and Agency Obligations [Member] | ||
Schedule of Investments [Line Items] | ||
Held to maturity, Less than 12 months, Fair Value | 11,403 | 11,995 |
Held to maturity, Less than 12 months, Unrealized/ Unrecognized Loss | (91) | (5) |
Held to maturity, Total, Fair Value | 11,403 | 11,995 |
Held to maturity, Total, Unrealized/ Unrecognized Loss | (91) | (5) |
Corporate [Member] | ||
Schedule of Investments [Line Items] | ||
Held to maturity, Less than 12 months, Fair Value | 2,481 | 25,615 |
Held to maturity, Less than 12 months, Unrealized/ Unrecognized Loss | (18) | (1,004) |
Held to maturity, 12 months or greater, Fair Value | 14,969 | 12,045 |
Held to maturity, 12 months or greater, Unrealized/ Unrecognized Loss | (109) | (455) |
Held to maturity, Total, Fair Value | 17,450 | 37,660 |
Held to maturity, Total, Unrealized/ Unrecognized Loss | (127) | (1,459) |
Mortgage-backed Securities - Collateralized Mortgage Obligations [Member] | ||
Schedule of Investments [Line Items] | ||
Held to maturity, Less than 12 months, Fair Value | 16,541 | 2,627 |
Held to maturity, Less than 12 months, Unrealized/ Unrecognized Loss | (138) | (31) |
Held to maturity, Total, Fair Value | 16,541 | 2,627 |
Held to maturity, Total, Unrealized/ Unrecognized Loss | (138) | $ (31) |
Mortgage-backed Securities - Commercial [Member] | ||
Schedule of Investments [Line Items] | ||
Held to maturity, Less than 12 months, Fair Value | 24,315 | |
Held to maturity, Less than 12 months, Unrealized/ Unrecognized Loss | (625) | |
Held to maturity, Total, Fair Value | 24,315 | |
Held to maturity, Total, Unrealized/ Unrecognized Loss | $ (625) |
Loans Receivable - Summary of L
Loans Receivable - Summary of Loans Receivable (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Jun. 30, 2019 |
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Loans receivable, before fees | $ 1,269,011 | $ 1,268,117 | ||||
Loans receivable | 1,269,020 | 1,269,586 | ||||
Allowance for loan losses | (7,865) | $ (8,677) | (8,639) | $ (8,346) | $ (6,216) | $ (5,664) |
Loans receivable, net | 1,261,155 | 1,260,947 | ||||
Residential [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Loans receivable, before fees | 229,008 | 255,382 | ||||
Commercial [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Loans receivable, before fees | 831,162 | 807,106 | ||||
Construction [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Loans receivable, before fees | 10,047 | 11,053 | ||||
Allowance for loan losses | (102) | (205) | (165) | (446) | (273) | (159) |
Commercial Loans [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Loans receivable, before fees | 171,314 | 164,257 | ||||
Allowance for loan losses | (848) | (1,201) | (1,124) | (1,553) | (953) | (1,130) |
Home Equity Lines Of Credit [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Loans receivable, before fees | 27,211 | 29,838 | ||||
Allowance for loan losses | (62) | (61) | (60) | (85) | (60) | (65) |
Consumer and Overdrafts [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Loans receivable, before fees | 269 | 481 | ||||
Allowance for loan losses | (3) | $ (4) | (4) | $ (13) | $ (10) | $ (11) |
Mortgage Loans [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Net deferred loan origination costs | 365 | 739 | ||||
Loans receivable | 1,070,582 | 1,074,280 | ||||
Commercial and Consumer Loans [Member] | ||||||
Loans and Leases Receivable Disclosure [Line Items] | ||||||
Net deferred loan origination costs | (356) | 730 | ||||
Loans receivable | $ 198,438 | $ 195,306 |
Loans Receivable - Summary of A
Loans Receivable - Summary of Activity in Allowance for Loan Losses by Portfolio Segment (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Loans and Leases Receivable Disclosure [Line Items] | ||||
Allowance for Loan Losses, Beginning Allowance | $ 8,677 | $ 6,216 | $ 8,639 | $ 5,664 |
Allowance for Loan Losses, Provision (credit) | (894) | 2,008 | (678) | 2,755 |
Allowance for Loan Losses, Charge-offs | (27) | (9) | (268) | (223) |
Allowance for Loan Losses, Recoveries | 109 | 131 | 172 | 150 |
Allowance for Loan Losses, Ending Allowance | 7,865 | 8,346 | 7,865 | 8,346 |
Residential Mortgages [Member] | ||||
Loans and Leases Receivable Disclosure [Line Items] | ||||
Allowance for Loan Losses, Beginning Allowance | 334 | 352 | 373 | 446 |
Allowance for Loan Losses, Provision (credit) | (4) | 102 | (49) | 34 |
Allowance for Loan Losses, Charge-offs | (31) | |||
Allowance for Loan Losses, Recoveries | 2 | 3 | 8 | 8 |
Allowance for Loan Losses, Ending Allowance | 332 | 457 | 332 | 457 |
Commercial Mortgages [Member] | ||||
Loans and Leases Receivable Disclosure [Line Items] | ||||
Allowance for Loan Losses, Beginning Allowance | 6,872 | 4,568 | 6,913 | 3,853 |
Allowance for Loan Losses, Provision (credit) | (354) | 1,099 | (395) | 1,814 |
Allowance for Loan Losses, Recoveries | 125 | 125 | ||
Allowance for Loan Losses, Ending Allowance | 6,518 | 5,792 | 6,518 | 5,792 |
Construction [Member] | ||||
Loans and Leases Receivable Disclosure [Line Items] | ||||
Allowance for Loan Losses, Beginning Allowance | 205 | 273 | 165 | 159 |
Allowance for Loan Losses, Provision (credit) | (103) | 173 | (63) | 287 |
Allowance for Loan Losses, Ending Allowance | 102 | 446 | 102 | 446 |
Commercial Loans [Member] | ||||
Loans and Leases Receivable Disclosure [Line Items] | ||||
Allowance for Loan Losses, Beginning Allowance | 1,201 | 953 | 1,124 | 1,130 |
Allowance for Loan Losses, Provision (credit) | (437) | 600 | (187) | 573 |
Allowance for Loan Losses, Charge-offs | (21) | (245) | (150) | |
Allowance for Loan Losses, Recoveries | 105 | 156 | ||
Allowance for Loan Losses, Ending Allowance | 848 | 1,553 | 848 | 1,553 |
Home Equity Lines Of Credit [Member] | ||||
Loans and Leases Receivable Disclosure [Line Items] | ||||
Allowance for Loan Losses, Beginning Allowance | 61 | 60 | 60 | 65 |
Allowance for Loan Losses, Provision (credit) | (1) | 23 | (4) | 10 |
Allowance for Loan Losses, Recoveries | 2 | 2 | 6 | 10 |
Allowance for Loan Losses, Ending Allowance | 62 | 85 | 62 | 85 |
Consumer and Overdrafts [Member] | ||||
Loans and Leases Receivable Disclosure [Line Items] | ||||
Allowance for Loan Losses, Beginning Allowance | 4 | 10 | 4 | 11 |
Allowance for Loan Losses, Provision (credit) | 5 | 11 | 20 | 37 |
Allowance for Loan Losses, Charge-offs | (6) | (9) | (23) | (42) |
Allowance for Loan Losses, Recoveries | 1 | 2 | 7 | |
Allowance for Loan Losses, Ending Allowance | $ 3 | $ 13 | $ 3 | $ 13 |
Loans Receivable - Summary of B
Loans Receivable - Summary of Balance in Allowance for Loan Losses and Recorded investment in Loans by Portfolio Segment, and Based on Impairment Method (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Jun. 30, 2019 |
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Individually Evaluated for Impairment | $ 4,387 | $ 4,719 | ||||
Loans, Collectively Evaluated for Impairment | 1,262,878 | 1,261,638 | ||||
Total | 1,269,011 | 1,268,117 | ||||
Allowance for Loan Losses, Individually Evaluated for Impairment | 123 | 123 | ||||
Allowance for Loan Losses, Collectively Evaluated for Impairment | 7,742 | 8,516 | ||||
Allowance for Loan Losses, Total | 7,865 | $ 8,677 | 8,639 | $ 8,346 | $ 6,216 | $ 5,664 |
Acquired with Deteriorated Credit Quality [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Acquired With Deteriorated Credit Quality | 1,746 | 1,760 | ||||
Allowance for Loan Losses, Acquired With Deteriorated Credit Quality | 0 | 0 | ||||
Residential Mortgages [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Individually Evaluated for Impairment | 2,238 | 2,448 | ||||
Loans, Collectively Evaluated for Impairment | 226,049 | 252,195 | ||||
Total | 229,008 | 255,382 | ||||
Allowance for Loan Losses, Individually Evaluated for Impairment | 114 | 118 | ||||
Allowance for Loan Losses, Collectively Evaluated for Impairment | 218 | 255 | ||||
Allowance for Loan Losses, Total | 332 | 334 | 373 | 457 | 352 | 446 |
Residential Mortgages [Member] | Acquired with Deteriorated Credit Quality [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Acquired With Deteriorated Credit Quality | 721 | 739 | ||||
Commercial Mortgages [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Collectively Evaluated for Impairment | 830,264 | 806,224 | ||||
Total | 831,162 | 807,106 | ||||
Allowance for Loan Losses, Collectively Evaluated for Impairment | 6,518 | 6,913 | ||||
Allowance for Loan Losses, Total | 6,518 | 6,872 | 6,913 | 5,792 | 4,568 | 3,853 |
Commercial Mortgages [Member] | Acquired with Deteriorated Credit Quality [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Acquired With Deteriorated Credit Quality | 898 | 882 | ||||
Construction [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Collectively Evaluated for Impairment | 10,047 | 11,053 | ||||
Total | 10,047 | 11,053 | ||||
Allowance for Loan Losses, Collectively Evaluated for Impairment | 102 | 165 | ||||
Allowance for Loan Losses, Total | 102 | 205 | 165 | 446 | 273 | 159 |
Construction [Member] | Acquired with Deteriorated Credit Quality [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for Loan Losses, Acquired With Deteriorated Credit Quality | 0 | 0 | ||||
Commercial Loans [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Individually Evaluated for Impairment | 1,739 | 1,921 | ||||
Loans, Collectively Evaluated for Impairment | 169,575 | 162,336 | ||||
Total | 171,314 | 164,257 | ||||
Allowance for Loan Losses, Individually Evaluated for Impairment | 1 | |||||
Allowance for Loan Losses, Collectively Evaluated for Impairment | 848 | 1,123 | ||||
Allowance for Loan Losses, Total | 848 | 1,201 | 1,124 | 1,553 | 953 | 1,130 |
Commercial Loans [Member] | Acquired with Deteriorated Credit Quality [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for Loan Losses, Acquired With Deteriorated Credit Quality | 0 | 0 | ||||
Home Equity Lines Of Credit [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Individually Evaluated for Impairment | 410 | 350 | ||||
Loans, Collectively Evaluated for Impairment | 26,674 | 29,349 | ||||
Total | 27,211 | 29,838 | ||||
Allowance for Loan Losses, Individually Evaluated for Impairment | 9 | 4 | ||||
Allowance for Loan Losses, Collectively Evaluated for Impairment | 53 | 56 | ||||
Allowance for Loan Losses, Total | 62 | 61 | 60 | 85 | 60 | 65 |
Home Equity Lines Of Credit [Member] | Acquired with Deteriorated Credit Quality [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Acquired With Deteriorated Credit Quality | 127 | 139 | ||||
Allowance for Loan Losses, Acquired With Deteriorated Credit Quality | 0 | 0 | ||||
Consumer and Overdrafts [Member] | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Loans, Collectively Evaluated for Impairment | 269 | 481 | ||||
Total | 269 | 481 | ||||
Allowance for Loan Losses, Collectively Evaluated for Impairment | 3 | 4 | ||||
Allowance for Loan Losses, Total | $ 3 | $ 4 | $ 4 | $ 13 | $ 10 | $ 11 |
Loans Receivable - Summary of_2
Loans Receivable - Summary of Loans Individually Evaluated for Impairment (Excluding Loans Acquired with Deteriorated Credit Quality) by Portfolio Segment (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Financing Receivable Impaired [Line Items] | ||
Impaired loans, unpaid principal balance | $ 4,589 | $ 4,923 |
Impaired loans, recorded investment | 4,387 | 4,719 |
Allowance for loan losses | 123 | 123 |
Residential Mortgages [Member] | ||
Financing Receivable Impaired [Line Items] | ||
Impaired loans with no related allowance recorded, unpaid principal balance | 1,926 | 2,123 |
Impaired loans with no related allowance recorded, recorded investment | 1,812 | 2,013 |
Impaired loans with an allowance recorded, unpaid principal balance | 365 | 372 |
Impaired loans with an allowance recorded, recorded investment | 426 | 435 |
Impaired loans, recorded investment | 2,238 | 2,448 |
Allowance for loan losses | 114 | 118 |
Commercial Loans [Member] | ||
Financing Receivable Impaired [Line Items] | ||
Impaired loans with no related allowance recorded, unpaid principal balance | 1,909 | 2,067 |
Impaired loans with no related allowance recorded, recorded investment | 1,739 | 1,897 |
Impaired loans with an allowance recorded, unpaid principal balance | 24 | |
Impaired loans with an allowance recorded, recorded investment | 24 | |
Impaired loans, recorded investment | 1,739 | 1,921 |
Allowance for loan losses | 1 | |
Home Equity Lines Of Credit [Member] | ||
Financing Receivable Impaired [Line Items] | ||
Impaired loans with no related allowance recorded, unpaid principal balance | 358 | 326 |
Impaired loans with no related allowance recorded, recorded investment | 379 | 339 |
Impaired loans with an allowance recorded, unpaid principal balance | 31 | 11 |
Impaired loans with an allowance recorded, recorded investment | 31 | 11 |
Impaired loans, recorded investment | 410 | 350 |
Allowance for loan losses | $ 9 | $ 4 |
Loans Receivable - Summary of_3
Loans Receivable - Summary of Average Recorded Investment and Interest Income Recognized on Loans Individually Evaluated for Impairment, by Portfolio Segment (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Financing Receivable Impaired [Line Items] | ||||
Impaired loans average recorded investment | $ 4,407 | $ 5,364 | $ 4,528 | $ 6,075 |
Impaired loans interest income recognized | 58 | 78 | 183 | 375 |
Residential Mortgages [Member] | ||||
Financing Receivable Impaired [Line Items] | ||||
Impaired loans with no related allowance recorded, average recorded investment | 1,822 | 2,060 | 1,905 | 2,050 |
Impaired loans with no related allowance recorded, interest income recognized | 7 | 13 | 27 | 40 |
Impaired loans with an allowance recorded, average recorded investment | 427 | 435 | 429 | 437 |
Impaired loans with an allowance recorded, interest income recognized | 4 | 4 | 11 | 11 |
Commercial Mortgages [Member] | ||||
Financing Receivable Impaired [Line Items] | ||||
Impaired loans with no related allowance recorded, average recorded investment | 485 | 946 | ||
Impaired loans with no related allowance recorded, interest income recognized | 9 | 149 | ||
Commercial Loans [Member] | ||||
Financing Receivable Impaired [Line Items] | ||||
Impaired loans with no related allowance recorded, average recorded investment | 1,749 | 1,932 | 1,786 | 2,015 |
Impaired loans with no related allowance recorded, interest income recognized | 47 | 51 | 144 | 154 |
Impaired loans with an allowance recorded, average recorded investment | 38 | 42 | ||
Impaired loans with an allowance recorded, interest income recognized | 1 | |||
Home Equity Lines Of Credit [Member] | ||||
Financing Receivable Impaired [Line Items] | ||||
Impaired loans with no related allowance recorded, average recorded investment | 379 | 403 | 384 | 574 |
Impaired loans with no related allowance recorded, interest income recognized | 7 | 1 | 20 | |
Impaired loans with an allowance recorded, average recorded investment | $ 30 | 11 | $ 24 | $ 11 |
Impaired loans with an allowance recorded, interest income reversal recognized | $ (6) |
Loans Receivable - Nonaccrual L
Loans Receivable - Nonaccrual Loans and in Loans Past Due over 90 Days Still on Accrual Status by Portfolio Segment (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | $ 1,646 | $ 1,795 |
Loans Past Due Over 90 Days and Still Accruing | 408 | |
Residential Mortgages [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 1,267 | 1,457 |
Commercial Mortgages [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Loans Past Due Over 90 Days and Still Accruing | 408 | |
Home Equity Lines Of Credit [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | $ 379 | $ 338 |
Loans Receivable - Additional I
Loans Receivable - Additional Information (Detail) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Mar. 31, 2021USD ($)Loan | Mar. 31, 2020USD ($)Loan | Mar. 31, 2021USD ($)Loan | Mar. 31, 2020USD ($)Loan | Jun. 30, 2020USD ($)Loan | |
Loans and Leases Receivable Disclosure [Line Items] | |||||
Number of loans classified as troubled debt restructurings | Loan | 13 | 13 | 14 | ||
Value of loans classified as troubled debt restructurings | $ 3,100,000 | $ 3,100,000 | $ 3,300,000 | ||
Troubled debt restructuring with carrying amount | 2,700,000 | $ 156,000,000 | 2,900,000 | ||
Specific reserves | 123,000 | 123,000 | 123,000 | ||
Commitment to lend to customers in addition to outstanding loans classified as troubled debt restructurings | $ 5,000 | $ 5,000 | |||
Troubled debt restructurings, number of modified loans | Loan | 0 | 1 | 0 | 2 | |
Troubled debt restructurings for which there was a payment default | Loan | 0 | 0 | 0 | 1 | |
Loans receivable | $ 1,269,020,000 | $ 1,269,020,000 | 1,269,586,000 | ||
Loans granted | 1,267,005,000 | 1,267,005,000 | 1,266,348,000 | ||
Provision (benefit) for loan losses | (894,000) | $ 2,008,000 | (678,000) | $ 2,755,000 | |
COVID-19 Pandemic [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Loans granted | 34,400,000 | 34,400,000 | 200,600,000 | ||
COVID-19 Pandemic [Member] | Pass [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Loans granted | 16,400,000 | 16,400,000 | 195,400,000 | ||
COVID-19 Pandemic [Member] | Special Mention [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Loans granted | 2,600,000 | 2,600,000 | |||
COVID-19 Pandemic [Member] | Substandard [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Loans granted | 15,300,000 | $ 15,300,000 | $ 5,200,000 | ||
Loan Payment Deferrals [Member] | COVID-19 Pandemic [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Number of loans | Loan | 35 | 293 | |||
Loans receivable | 34,400,000 | $ 34,400,000 | $ 200,600,000 | ||
Residential [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Troubled debt restructuring with carrying amount | 370,000 | ||||
Increase (decrease) allowance for loan loss | $ 0 | ||||
Residential Mortgage Loans and Home Equity Lines of Credit [Member] | Loan Payment Deferrals [Member] | COVID-19 Pandemic [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Number of loans | Loan | 31 | ||||
Loans receivable | 9,700,000 | $ 9,700,000 | |||
Commercial Mortgage, Construction and Commercial Loans [Member] | Loan Payment Deferrals [Member] | COVID-19 Pandemic [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Number of loans | Loan | 35 | ||||
Loans receivable | 41,600,000 | $ 41,600,000 | |||
Purchased Credit Impaired Loans [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Provision (benefit) for loan losses | 0 | $ 0 | 0 | $ 0 | |
90 Days or More Past Due [Member] | |||||
Loans and Leases Receivable Disclosure [Line Items] | |||||
Acquired loans accounted for as purchased credit impaired loans | $ 372,000 | $ 372,000 | $ 392,000 |
Loans Receivable - Aging of Rec
Loans Receivable - Aging of Recorded Investment in Past Due Loans (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | $ 2,006 | $ 1,769 |
Current | 1,267,005 | 1,266,348 |
Total | 1,269,011 | 1,268,117 |
30-59 Days Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 54 | 615 |
60-89 Days Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 226 | 10 |
90 Days or More Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 1,726 | 1,144 |
Residential Mortgages [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 939 | 1,311 |
Current | 228,069 | 254,071 |
Total | 229,008 | 255,382 |
Residential Mortgages [Member] | 30-59 Days Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 495 | |
Residential Mortgages [Member] | 60-89 Days Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 10 | |
Residential Mortgages [Member] | 90 Days or More Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 939 | 806 |
Commercial Mortgages [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 408 | |
Current | 830,754 | 807,106 |
Total | 831,162 | 807,106 |
Commercial Mortgages [Member] | 90 Days or More Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 408 | |
Construction [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 10,047 | 11,053 |
Total | 10,047 | 11,053 |
Commercial Loans [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 280 | 76 |
Current | 171,034 | 164,181 |
Total | 171,314 | 164,257 |
Commercial Loans [Member] | 30-59 Days Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 54 | 76 |
Commercial Loans [Member] | 60-89 Days Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 226 | |
Home Equity Lines Of Credit [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 379 | 382 |
Current | 26,832 | 29,456 |
Total | 27,211 | 29,838 |
Home Equity Lines Of Credit [Member] | 30-59 Days Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 44 | |
Home Equity Lines Of Credit [Member] | 90 Days or More Past Due [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Past Due | 379 | 338 |
Consumer and Overdrafts [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 269 | 481 |
Total | $ 269 | $ 481 |
Loans Receivable - Aging of R_2
Loans Receivable - Aging of Recorded Investment in Past Due Loans (Parenthetical) (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | $ 1,267,005 | $ 1,266,348 |
COVID-19 Pandemic [Member] | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | $ 34,400 | $ 200,600 |
Loans Receivable - Summary of R
Loans Receivable - Summary of Risk Category of Loans by Portfolio Segment (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | $ 1,269,011 | $ 1,268,117 |
Pass [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 1,242,393 | 1,256,217 |
Special Mention [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 4,981 | 4,562 |
Substandard [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 21,637 | 7,338 |
Residential Mortgages [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 229,008 | 255,382 |
Residential Mortgages [Member] | Pass [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 224,725 | 252,604 |
Residential Mortgages [Member] | Special Mention [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 2,358 | 687 |
Residential Mortgages [Member] | Substandard [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 1,925 | 2,091 |
Commercial Mortgages [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 831,162 | 807,106 |
Commercial Mortgages [Member] | Pass [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 814,173 | 803,048 |
Commercial Mortgages [Member] | Special Mention [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 1,627 | 3,176 |
Commercial Mortgages [Member] | Substandard [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 15,362 | 882 |
Construction [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 10,047 | 11,053 |
Construction [Member] | Pass [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 10,047 | 11,053 |
Commercial Loans [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 171,314 | 164,257 |
Commercial Loans [Member] | Pass [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 167,309 | 160,137 |
Commercial Loans [Member] | Special Mention [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 94 | 201 |
Commercial Loans [Member] | Substandard [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 3,911 | 3,919 |
Home Equity Lines Of Credit [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 27,211 | 29,838 |
Home Equity Lines Of Credit [Member] | Pass [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 25,870 | 28,894 |
Home Equity Lines Of Credit [Member] | Special Mention [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 902 | 498 |
Home Equity Lines Of Credit [Member] | Substandard [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 439 | 446 |
Consumer and Overdrafts [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | 269 | 481 |
Consumer and Overdrafts [Member] | Pass [Member] | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Total loans | $ 269 | $ 481 |
Loans Receivable - Schedule of
Loans Receivable - Schedule of Carrying Amount of Purchased Credit Impaired Loans (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying amount of loans | $ 1,261,155 | $ 1,260,947 |
Acquired with Deteriorated Credit Quality [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying amount of loans | 1,746 | 1,760 |
Acquired with Deteriorated Credit Quality [Member] | Home Equity Lines Of Credit [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying amount of loans | 127 | 139 |
Residential Mortgages [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying amount of loans | 721 | 739 |
Commercial Mortgages [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying amount of loans | $ 898 | $ 882 |
Loans Receivable - Schedule o_2
Loans Receivable - Schedule of Carrying Amount of Purchased Credit Impaired Loans (Parenthetical) (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Acquired with Deteriorated Credit Quality [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying amount of loans, allowance | $ 0 | $ 0 |
Loans Receivable - Summary of_4
Loans Receivable - Summary of Accretable Yield, or Income Expected to be Collected for Acquired Loans (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Certain Loans Acquired in Transfer Accounted for as Debt Securities [Abstract] | ||||
Beginning balance | $ 147 | $ 174 | $ 156 | $ 192 |
Accretion income | (9) | (9) | (18) | (27) |
Ending balance | $ 138 | $ 165 | $ 138 | $ 165 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) - Summary of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Mar. 31, 2021 | Mar. 31, 2020 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Beginning Balance | $ 269,324 | $ 273,679 | $ 273,713 | $ 279,839 | $ 281,522 | $ 281,307 | $ 273,713 | $ 281,307 |
Total other comprehensive (loss) income | (235) | 271 | 187 | 244 | 360 | 256 | 223 | 860 |
Ending Balance | 271,297 | 269,324 | 273,679 | 272,417 | 279,839 | 281,522 | 271,297 | 272,417 |
Net Unrealized Gain (Loss) on Available for Sale Securities [Member] | ||||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Beginning Balance | 413 | 428 | (34) | (209) | 428 | (209) | ||
Other comprehensive (loss) income before reclassifications | (565) | 186 | (584) | 406 | ||||
Amounts reclassified from accumulated other comprehensive income | (52) | (20) | (52) | (20) | ||||
Less tax effect | 129 | (35) | 133 | (80) | ||||
Total other comprehensive (loss) income | (488) | 131 | (503) | 306 | ||||
Ending Balance | (75) | 413 | 97 | (34) | (75) | 97 | ||
Unrealized Losses on Retirement Plans [Member] | Pension Benefits [Member] | ||||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Beginning Balance | (6,153) | (6,605) | (4,207) | (4,631) | (6,605) | (4,631) | ||
Amounts reclassified from accumulated other comprehensive income | 305 | 132 | 877 | 668 | ||||
Less tax effect | (64) | (27) | (184) | (139) | ||||
Total other comprehensive (loss) income | 241 | 105 | 693 | 529 | ||||
Ending Balance | (5,912) | (6,153) | (4,102) | (4,207) | (5,912) | (4,102) | ||
Unrealized Losses on Retirement Plans [Member] | SERP Benefits [Member] | ||||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Beginning Balance | (205) | (226) | (233) | (250) | (226) | (250) | ||
Amounts reclassified from accumulated other comprehensive income | 14 | 11 | 42 | 34 | ||||
Less tax effect | (2) | (3) | (9) | (9) | ||||
Total other comprehensive (loss) income | 12 | 8 | 33 | 25 | ||||
Ending Balance | (193) | (205) | (225) | (233) | (193) | (225) | ||
Accumulated Other Comprehensive Income (Loss) [Member] | ||||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Beginning Balance | (5,945) | (6,216) | (6,403) | (4,474) | (4,834) | (5,090) | (6,403) | (5,090) |
Other comprehensive (loss) income before reclassifications | (565) | 186 | (584) | 406 | ||||
Amounts reclassified from accumulated other comprehensive income | 267 | 123 | 867 | 682 | ||||
Less tax effect | 63 | (65) | (60) | (228) | ||||
Total other comprehensive (loss) income | (235) | 271 | 187 | 244 | 360 | 256 | 223 | 860 |
Ending Balance | $ (6,180) | $ (5,945) | $ (6,216) | $ (4,230) | $ (4,474) | $ (4,834) | $ (6,180) | $ (4,230) |
Post-Retirement Benefits - Addi
Post-Retirement Benefits - Additional Information (Detail) - USD ($) | Apr. 20, 2017 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 |
Compensation And Retirement Disclosure [Abstract] | ||||||
Effective date of freezing of the defined benefit pension plan | May 1, 2017 | |||||
Defined benefit plan, contributions by employer | $ 0 | $ 0 | ||||
ESOP shares | 1,453,209 | 1,444,164 | 1,444,164 | 1,441,735 | ||
Stock price | $ 10 | |||||
ESOP payable term | 15 years | |||||
ESOP prime rate percentage | 3.25% | |||||
ESOP borrowing | $ 10,700,000 | $ 10,700,000 | ||||
Number of shares committed to be released per year through 2032 | 96,881 | 96,881 | ||||
ESOP compensation | $ 392,000 | $ 438,000 | $ 1,053,000 | $ 1,415,000 |
Post-Retirement Benefits - Sche
Post-Retirement Benefits - Schedule of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Income (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Employee Pension Plan [Member] | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Interest cost | $ 136 | $ 180 | $ 409 | $ 540 |
Expected return on plan assets | (455) | (479) | (1,366) | (1,436) |
Amortization of prior net loss | 241 | 132 | 720 | 396 |
Settlement charges | 65 | 158 | 272 | |
Net periodic (benefit) cost | (13) | (167) | (79) | (228) |
Supplemental Retirement Plan [Member] | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Service cost | 130 | 90 | 311 | 248 |
Interest cost | 18 | 28 | 65 | 89 |
Amortization of prior net loss | 14 | 11 | 42 | 34 |
Net periodic (benefit) cost | $ 162 | $ 129 | $ 418 | $ 371 |
Post-Retirement Benefits - Shar
Post-Retirement Benefits - Shares Held by ESOP (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 | Apr. 20, 2017 |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |||
Allocated to participants | 402,362 | 327,206 | |
Unearned | 1,041,802 | 1,114,529 | |
Total ESOP shares | 1,444,164 | 1,441,735 | 1,453,209 |
Fair value of unearned shares | $ 17,304 | $ 14,132 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - Additional Information (Detail) | 3 Months Ended | 9 Months Ended | ||||||
Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2020USD ($) | Jun. 30, 2020USD ($) | Dec. 31, 2019USD ($) | Jun. 30, 2019USD ($) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||
Fair value transfers between levels | $ 0 | $ 0 | $ 0 | $ 0 | ||||
Carrying amount of loans | 1,261,155,000 | 1,261,155,000 | $ 1,260,947,000 | |||||
Remaining valuation allowance | 7,865,000 | 8,346,000 | 7,865,000 | 8,346,000 | $ 8,677,000 | 8,639,000 | $ 6,216,000 | $ 5,664,000 |
Net charge-offs | 27,000 | 9,000 | 268,000 | 223,000 | ||||
Provision (benefit) for loan losses | (894,000) | $ 2,008,000 | (678,000) | 2,755,000 | ||||
Impaired Loans [Member] | ||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||
Carrying amount of loans | 456,000 | 456,000 | 547,000 | |||||
Remaining valuation allowance | $ 123,000 | 123,000 | $ 123,000 | |||||
Net charge-offs | 0 | 0 | ||||||
Provision (benefit) for loan losses | $ 1,000 | $ 6,000 | ||||||
Minimum [Member] | Measurement Input, Discount Rates [Member] | ||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||
Discount rates | 0.10 | 0.10 | ||||||
Maximum [Member] | Measurement Input, Discount Rates [Member] | ||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||
Discount rates | 0.20 | 0.20 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments - Summary of Assets and Liabilities Measured at Fair Value (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Measured on a Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | $ 42,035 | $ 45,731 |
Total liabilities at fair value | 4,425 | 8,305 |
Measured on a Recurring Basis [Member] | U.S. Government and Agency Obligations [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 1,004 | 11,049 |
Measured on a Recurring Basis [Member] | Corporate [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 8,105 | 5,120 |
Measured on a Recurring Basis [Member] | State and Municipal [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 6,864 | |
Measured on a Recurring Basis [Member] | Mortgage-backed Securities - Residential [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 21,637 | 21,257 |
Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 333 | 424 |
Impaired Loans [Member] | Residential Mortgages [Member] | Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 312 | 317 |
Impaired Loans [Member] | Home Equity Lines Of Credit [Member] | Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 21 | 7 |
Impaired Loans [Member] | Commercial Loans [Member] | Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 100 | |
Derivatives - Interest Rate Contracts [Member] | Measured on a Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 4,425 | 8,305 |
Total liabilities at fair value | 4,425 | 8,305 |
Level 2 [Member] | Measured on a Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 42,035 | 45,731 |
Total liabilities at fair value | 4,425 | 8,305 |
Level 2 [Member] | Measured on a Recurring Basis [Member] | U.S. Government and Agency Obligations [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 1,004 | 11,049 |
Level 2 [Member] | Measured on a Recurring Basis [Member] | Corporate [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 8,105 | 5,120 |
Level 2 [Member] | Measured on a Recurring Basis [Member] | State and Municipal [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 6,864 | |
Level 2 [Member] | Measured on a Recurring Basis [Member] | Mortgage-backed Securities - Residential [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 21,637 | 21,257 |
Level 2 [Member] | Derivatives - Interest Rate Contracts [Member] | Measured on a Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 4,425 | 8,305 |
Total liabilities at fair value | 4,425 | 8,305 |
Level 3 [Member] | Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 333 | 424 |
Level 3 [Member] | Impaired Loans [Member] | Residential Mortgages [Member] | Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | 312 | 317 |
Level 3 [Member] | Impaired Loans [Member] | Home Equity Lines Of Credit [Member] | Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | $ 21 | 7 |
Level 3 [Member] | Impaired Loans [Member] | Commercial Loans [Member] | Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets at fair value | $ 100 |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments - Summary of Quantitative Information about Level 3 Fair Value Measurements for Selected Financial Instruments Measured at Fair Value on Non-recurring Basis (Detail) $ in Thousands | Mar. 31, 2021USD ($) | Jun. 30, 2020USD ($) |
Minimum [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.10 | |
Maximum [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.20 | |
Measured on a Non-Recurring Basis [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ 333 | $ 424 |
Measured on a Non-Recurring Basis [Member] | Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 333 | 424 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Residential [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 312 | 317 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Residential [Member] | Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 312 | 317 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Residential [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 312 | 316 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Home Equity Lines Of Credit [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 21 | 7 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Home Equity Lines Of Credit [Member] | Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 21 | 7 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Home Equity Lines Of Credit [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ 21 | $ 7 |
Range or Rate Used | 0.063 | |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Commercial Loans [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ 100 | |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Commercial Loans [Member] | Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 100 | |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Commercial Loans [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ 100 | |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Minimum [Member] | Residential [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.054 | 0.054 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Minimum [Member] | Home Equity Lines Of Credit [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.054 | |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Minimum [Member] | Commercial Loans [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.068 | |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Maximum [Member] | Residential [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.063 | 0.063 |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Maximum [Member] | Home Equity Lines Of Credit [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.063 | |
Measured on a Non-Recurring Basis [Member] | Impaired Loans [Member] | Maximum [Member] | Commercial Loans [Member] | Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rates [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Range or Rate Used | 0.075 |
Fair Value of Financial Instr_6
Fair Value of Financial Instruments - Summary of Carrying Amounts and Estimated Fair Values of Bank's Financial Assets and Liabilities (Detail) - USD ($) $ in Thousands | Mar. 31, 2021 | Jun. 30, 2020 |
Financial assets: | ||
Investment securities held to maturity | $ 313,974 | $ 281,497 |
Investment securities available for sale | 37,610 | 37,426 |
Carrying Amount [Member] | ||
Financial assets: | ||
Cash and cash equivalents | 169,314 | 136,302 |
Investment securities held to maturity | 309,692 | 275,772 |
Investment securities available for sale | 37,610 | 37,426 |
Loans receivable, net | 1,261,155 | 1,260,947 |
Accrued interest receivable | 6,731 | 6,880 |
FHLB stock | 5,854 | 6,308 |
Financial liabilities: | ||
Mortgage escrow funds | 9,252 | 10,123 |
Accrued interest payable | 228 | 246 |
FHLB advances | 95,991 | 106,089 |
Carrying Amount [Member] | Derivatives - Interest Rate Contracts [Member] | ||
Financial assets: | ||
Derivative assets - interest rate contracts | 4,425 | 8,305 |
Financial liabilities: | ||
Derivative liabilities - interest rate contracts | 4,425 | 8,305 |
Carrying Amount [Member] | Demand, NOW, Money Market Deposits and Savings Accounts [Member] | ||
Financial liabilities: | ||
Time deposits | 1,046,464 | 926,989 |
Carrying Amount [Member] | Time Deposits [Member] | ||
Financial liabilities: | ||
Time deposits | 407,826 | 446,246 |
Total [Member] | ||
Financial assets: | ||
Cash and cash equivalents | 169,314 | 136,302 |
Investment securities held to maturity | 313,974 | 281,497 |
Investment securities available for sale | 37,610 | 37,426 |
Loans receivable, net | 1,240,645 | 1,240,440 |
Accrued interest receivable | 6,731 | 6,880 |
Financial liabilities: | ||
Mortgage escrow funds | 9,252 | 10,123 |
Accrued interest payable | 228 | 246 |
FHLB advances | 99,550 | 110,937 |
Total [Member] | Derivatives - Interest Rate Contracts [Member] | ||
Financial assets: | ||
Derivative assets - interest rate contracts | 4,425 | 8,305 |
Financial liabilities: | ||
Derivative liabilities - interest rate contracts | 4,425 | 8,305 |
Total [Member] | Demand, NOW, Money Market Deposits and Savings Accounts [Member] | ||
Financial liabilities: | ||
Time deposits | 1,046,464 | 926,989 |
Total [Member] | Time Deposits [Member] | ||
Financial liabilities: | ||
Time deposits | 414,737 | 456,109 |
Level 1 [Member] | ||
Financial assets: | ||
Cash and cash equivalents | 169,314 | 136,302 |
Financial liabilities: | ||
Mortgage escrow funds | 9,252 | 10,123 |
Accrued interest payable | 1 | 1 |
Level 1 [Member] | Demand, NOW, Money Market Deposits and Savings Accounts [Member] | ||
Financial liabilities: | ||
Time deposits | 1,046,464 | 926,989 |
Level 2 [Member] | ||
Financial assets: | ||
Investment securities held to maturity | 286,539 | 276,847 |
Investment securities available for sale | 37,610 | 37,426 |
Accrued interest receivable | 1,300 | 997 |
Financial liabilities: | ||
Accrued interest payable | 227 | 245 |
FHLB advances | 99,550 | 110,937 |
Level 2 [Member] | Derivatives - Interest Rate Contracts [Member] | ||
Financial assets: | ||
Derivative assets - interest rate contracts | 4,425 | 8,305 |
Financial liabilities: | ||
Derivative liabilities - interest rate contracts | 4,425 | 8,305 |
Level 2 [Member] | Time Deposits [Member] | ||
Financial liabilities: | ||
Time deposits | 414,737 | 456,109 |
Level 3 [Member] | ||
Financial assets: | ||
Investment securities held to maturity | 27,435 | 4,650 |
Loans receivable, net | 1,240,645 | 1,240,440 |
Accrued interest receivable | $ 5,431 | $ 5,883 |
Regulatory Matters - Summary of
Regulatory Matters - Summary of Bank's Actual Capital Amounts and Ratios Compared to Required Ratios for Minimum Capital Adequacy and for Classification as Well Capitalized (Detail) - PCSB Bank [Member] $ in Thousands | Mar. 31, 2021USD ($) | Jun. 30, 2020USD ($) |
Compliance With Regulatory Capital Requirements Under Banking Regulations [Line Items] | ||
Leverage (Tier 1), Bank Actual Amount | $ 230,237 | $ 220,310 |
Common Tier 1, Bank Actual Amount | 230,237 | 220,310 |
Tier 1, Bank Actual Amount | 230,237 | 220,310 |
Total, Bank Actual Amount | $ 238,102 | $ 228,949 |
Leverage (Tier 1), Bank Actual Ratio | 12.8 | 12.5 |
Common Tier 1, Bank Actual Ratio | 17.7 | 17 |
Tier 1, Bank Actual Ratio | 17.7 | 17 |
Total, Bank Actual Ratio | 18.3 | 17 |
Leverage (Tier 1), For Capital Adequacy Purposes Amount | $ 72,197 | $ 70,432 |
Common Tier 1, For Capital Adequacy Purposes Amount | 58,462 | 58,389 |
Tier 1, For Capital Adequacy Purposes Amount | 77,950 | 77,852 |
Total, For Capital Adequacy Purposes Amount | $ 103,933 | $ 103,802 |
Leverage (Tier 1), For Capital Adequacy Purposes Ratio | 4 | 4 |
Common Tier 1, For Capital Adequacy Purposes Ratio | 4.50% | 4.50% |
Tier 1, For Capital Adequacy Purposes Ratio | 6 | 6 |
Total, For Capital Adequacy Purposes Ratio | 8 | 8 |
Leverage (Tier 1), To Be Well Capitalized Under Prompt Corrective Action Provisions Amount | $ 90,247 | $ 88,040 |
Common Tier 1, To Be Well Capitalized Under Prompt Corrective Action Provisions Amount | 84,445 | 84,339 |
Tier 1, To Be Well Capitalized Under Prompt Corrective Action Provisions Amount | 103,933 | 103,802 |
Total, To Be Well Capitalized Under Prompt Corrective Action Provisions Amount | $ 129,916 | $ 129,753 |
Leverage (Tier 1), To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio | 5 | 5 |
Common Tier 1, To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio | 6.50% | 6.50% |
Tier 1, To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio | 8 | 8 |
Total, To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio | 10 | 10 |
Regulatory Matters - Additional
Regulatory Matters - Additional Information (Detail) | 9 Months Ended | |
Mar. 31, 2021 | Jun. 30, 2020 | |
Compliance With Regulatory Capital Requirements Under Banking Regulations [Line Items] | ||
Capital conservation buffer percentage at beginning period | 2.50% | 2.50% |
Minimum [Member] | ||
Compliance With Regulatory Capital Requirements Under Banking Regulations [Line Items] | ||
Capital conservation buffer percentage required under regulatory | 2.50% |
Earnings Per Share ("EPS") - Sc
Earnings Per Share ("EPS") - Schedule of Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Mar. 31, 2021 | Mar. 31, 2020 | |
Earnings Per Share [Abstract] | ||||||||
Net income applicable to common stock | $ 3,592 | $ 2,694 | $ 2,728 | $ 1,217 | $ 2,353 | $ 2,829 | $ 9,014 | $ 6,399 |
Average number of common shares outstanding | 15,684,763 | 16,587,563 | 16,022,046 | 16,927,496 | ||||
Less: Average unallocated ESOP shares | (1,053,641) | (1,150,390) | (1,077,949) | (1,174,787) | ||||
Average number of common shares outstanding used to calculate basic earnings per common share | 14,631,122 | 15,437,173 | 14,944,097 | 15,752,709 | ||||
Effect of equity-based awards | 1,220 | 10,044 | 567 | 61,613 | ||||
Average number of common shares outstanding used to calculate diluted earnings per common share | 14,632,342 | 15,447,217 | 14,944,664 | 15,814,322 | ||||
Earnings per common share: | ||||||||
Basic | $ 0.25 | $ 0.08 | $ 0.60 | $ 0.41 | ||||
Diluted | $ 0.25 | $ 0.08 | $ 0.60 | $ 0.40 |
Earnings Per Share ("EPS") - Ad
Earnings Per Share ("EPS") - Additional Information (Detail) - shares | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Stock Options [Member] | ||||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of earnings per share, amount | 1,323,334 | 1,339,293 | 1,338,000 | 1,339,293 |
Derivatives and Hedging - Summa
Derivatives and Hedging - Summary Information About Interest Rate Swaps (Detail) - USD ($) | 9 Months Ended | 12 Months Ended |
Mar. 31, 2021 | Jun. 30, 2020 | |
Derivative Instruments And Hedging Activities Disclosure [Abstract] | ||
Notional amounts | $ 183,571,000 | $ 159,242,000 |
Weighted average pay rates | 2.55% | 2.54% |
Weighted average receive rates | 2.55% | 2.54% |
Weighted average maturity | 8 years 8 months 15 days | 9 years 3 months 21 days |
Revenue From Contracts With C_3
Revenue From Contracts With Customers - Summary of Sources of Revenue from Contracts with Customers (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | ||
Noninterest income | |||||
Service charges on deposits | $ 173,000 | $ 236,000 | $ 531,000 | $ 737,000 | |
Interchange fees | 128,000 | 95,000 | 392,000 | 324,000 | |
Other | [1] | 52,000 | 35,000 | 115,000 | 109,000 |
Fees and service charges | 353,000 | 366,000 | 1,038,000 | 1,170,000 | |
Bank-owned life insurance | [1] | 120,000 | 128,000 | 381,000 | 399,000 |
Swap income | [1] | 367,000 | 170,000 | ||
Gains on sales of securities | [1] | 113,000 | 38,000 | 113,000 | 38,000 |
Net gain on sale of foreclosed real estate | 49,000 | 87,000 | |||
Other | [1] | 6,000 | (1,000) | 30,000 | 28,000 |
Other noninterest income | 6,000 | 48,000 | 30,000 | 115,000 | |
Total noninterest income | $ 592,000 | $ 580,000 | $ 1,929,000 | $ 1,892,000 | |
[1] | Not within the scope of ASC 606 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Oct. 24, 2018 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Stock-based compensation | $ 2,460,000 | $ 2,487,000 | |||
Number of other than stock options granted | 3,000 | ||||
Number of shares granted | 6,000 | ||||
Stock Options [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Unrecognized compensation cost | $ 3,200,000 | $ 3,200,000 | |||
Expected weighted-average period for cost recognition | 2 years 8 months 12 days | ||||
Restricted Stock Awards [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Unrecognized compensation cost | 5,500,000 | $ 5,500,000 | |||
Expected weighted-average period for cost recognition | 2 years 8 months 12 days | ||||
2018 Equity Incentive Plan [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Number of shares authorized for issuance | 2,543,115 | ||||
Stock-based compensation | $ 809,000 | $ 829,000 | $ 2,500,000 | $ 2,500,000 | |
2018 Equity Incentive Plan [Member] | Stock Options [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Number of shares authorized for issuance | 1,816,511 | 1,816,511 | 1,816,511 | ||
Contractual term | 10 years | ||||
Number of shares granted | 1,308,963 | ||||
2018 Equity Incentive Plan [Member] | Stock Options [Member] | Annual Vesting on Each Anniversary [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Awards vesting percentage for year | 20.00% | ||||
2018 Equity Incentive Plan [Member] | Stock Options [Member] | Maximum [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Vesting period | 5 years | ||||
2018 Equity Incentive Plan [Member] | Stock Options [Member] | Minimum [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Vesting period | 3 years | ||||
2018 Equity Incentive Plan [Member] | Restricted Stock and Restricted Stock Units [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Number of shares authorized for issuance | 726,604 | ||||
2018 Equity Incentive Plan [Member] | Restricted Stock Awards [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Number of other than stock options granted | 541,467 | ||||
Number of shares available for grant | 726,604 | 726,604 | |||
2018 Equity Incentive Plan [Member] | Restricted Stock Awards [Member] | Annual Vesting on Each Anniversary [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Awards vesting percentage for year | 20.00% | ||||
2018 Equity Incentive Plan [Member] | Restricted Stock Awards [Member] | Maximum [Member] | |||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||
Vesting period | 5 years |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of RSA activity (Detail) | 9 Months Ended |
Mar. 31, 2021$ / sharesshares | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Number of Shares, Unvested granted shares outstanding beginning balance | shares | 437,737 |
Number of Shares, granted | shares | 3,000 |
Number of Shares, vested | shares | (109,439) |
Number of Shares, forfeited | shares | (8,718) |
Number of Shares, Unvested granted shares outstanding ending balance | shares | 322,580 |
Weighted-Average Grant Date Fair Value, Unvested granted shares outstanding beginning balance | $ / shares | $ 19.02 |
Weighted-Average Grant Date Fair Value, Shares granted | $ / shares | 12.34 |
Weighted-Average Grant Date Fair Value, Shares vested | $ / shares | 19.02 |
Weighted-Average Grant Date Fair Value, Forfeited | $ / shares | 19.40 |
Weighted-Average Grant Date Fair Value, Unvested granted shares outstanding ending balance | $ / shares | $ 18.95 |
Share-Based Compensation - Summ
Share-Based Compensation - Summary of Fair Value of Options Granted Using Weighted-Average Assumptions as of Grant Date (Detail) - Stock Options [Member] | 9 Months Ended |
Mar. 31, 2021$ / shares | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Risk-free interest rate | 0.39% |
Expected term (in years) | 6 years 3 months |
Expected stock price volatility | 35.75% |
Dividend yield | 1.30% |
Weighted average fair value of options granted | $ 3.72 |
Share-Based Compensation - Su_2
Share-Based Compensation - Summary of Activity Related to Stock Options Granted under Plan (Detail) $ / shares in Units, $ in Thousands | 9 Months Ended |
Mar. 31, 2021USD ($)$ / sharesshares | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Number of Options, outstanding beginning balance | shares | 1,339,293 |
Number of Options, granted | shares | 6,000 |
Number of Options, expired | shares | (14,532) |
Number of Options, forfeited | shares | (21,798) |
Number of Options, outstanding ending balance | shares | 1,308,963 |
Number of Option, Exercisable at December 31, 2020 | shares | 521,185 |
Weighted-Average Exercise Price, Option outstanding beginning balance | $ / shares | $ 19.04 |
Weighted-Average Exercise Price, Option granted | $ / shares | 12.34 |
Weighted-Average Exercise Price, Option expired | $ / shares | 19.40 |
Weighted-Average Exercise Price, Option forfeited | $ / shares | 19.40 |
Weighted-Average Exercise Price, Option outstanding ending balance | $ / shares | 19 |
Weighted-Average Excercise Price, Exercisable at December 31, 2020 | $ / shares | $ 19.03 |
Weighted-Average Remaining Contractual Years, Option outstanding | 7 years 7 months 6 days |
Weighted-Average Remaining Contractual Years, Option Exercisable | 7 years 7 months 6 days |
Aggregate Intrinsic Value, Option outstanding | $ | $ 26 |
Leases - Additional Information
Leases - Additional Information (Detail) | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021USD ($)BranchOfficeAdministrativeOffice | Mar. 31, 2020USD ($) | Mar. 31, 2021USD ($)BranchOfficeAdministrativeOffice | Mar. 31, 2020USD ($) | |
Lessee Lease Description [Line Items] | ||||
Number of branch offices in real estate lease | BranchOffice | 11 | 11 | ||
Number of administrative office in real estate lease | AdministrativeOffice | 1 | 1 | ||
Lease maturity start year | 2022 | |||
Lease maturity end year | 2041 | |||
Lease option to extend | some of which include lessee options to extend the lease term. | |||
Operating lease, weighted average remaining lease terms | 9 years 7 months 13 days | 9 years 7 months 13 days | ||
Lessee, operating lease, description | The operating lease asset and lease liability are determined at the commencement date of the lease based on the present value of the lease payments. | |||
Operating lease, weighted average discount rate, percent | 2.37% | 2.37% | ||
Short-term lease cost | $ 0 | $ 0 | $ 0 | $ 0 |
Sale and leaseback transactions with related parties | 0 | 0 | 0 | 0 |
Operating lease, right-of-use asset | $ 10,100,000 | $ 10,100,000 | ||
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Premises and equipment, net | Premises and equipment, net | ||
Operating lease, liability | $ 10,367,000 | $ 10,367,000 | ||
Operating Lease, Liability, Statement of Financial Position [Extensible List] | Other liabilities | Other liabilities | ||
Occupancy and Equipment Expense [Member] | ||||
Lessee Lease Description [Line Items] | ||||
Operating lease, cost | $ 501,000 | $ 501,000 | $ 1,500,000 | $ 1,500,000 |
Maximum [Member] | ||||
Lessee Lease Description [Line Items] | ||||
Lessee, operating lease, original term | 12 months | 12 months |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments (Detail) $ in Thousands | Mar. 31, 2021USD ($) |
Leases [Abstract] | |
2021 | $ 507 |
2022 | 2,027 |
2023 | 1,940 |
2024 | 1,569 |
2025 | 1,276 |
Thereafter | 4,550 |
Total future minimum lease payments (undiscounted) | 11,869 |
Discounting effect on cash flows | (1,502) |
Lease liability (discounted) | $ 10,367 |
Operating Lease, Liability, Statement of Financial Position [Extensible List] | Other liabilities |